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ABSTRACT 
Postural instability leading to falls is one of the major unmet needs in the treatment of 
Parkinson’s disease (PD). The progression of postural instability is not well understood, and a better 
understanding of the biomechanics underlying the progression of postural instability may be instrumental 
in the development of more sensitive clinical measures of postural instability and fall risk in PD. The 
biomechanical analysis of the response to a balance perturbation provides an opportunity to better 
understand postural instability in PD. This study examined the compensatory stepping response to a 
backwards pull in participants with moderate PD compared to age-range matched healthy controls. The 
first study investigated the overall response to a balance disturbance in moderate PD, and found that 
patients with moderate PD utilized more steps to regain balance, had a longer weight shift time, and used 
a base-width neutral step as a strategy to regain balance, compared to controls. The second study further 
investigated the compensatory response by focusing on the preparation phase and found that participants 
with moderate PD used multiple anticipatory postural adjustments (APAs), resulting in longer liftoff 
times and significantly different movement in the center of pressure prior to liftoff compared to healthy 
controls. The third study investigated the effects of PD and step strategy (single step, multiple steps, and a 
base-width neutral step) on balance recovery and found that participants with moderate PD took 
significantly longer to recover balance, and that the type of strategy used to respond to the disturbance 
significantly impacted recovery time. Additionally, the use of a base-width neutral step as the first step in 
the response emerged as a strategy that has not been previously documented and significantly delays 
balance recovery. These results suggest that moderate PD significantly impairs the compensatory 
response to a backwards pull. Furthermore, this impairment could be attributed to a delay in the 
preparation phase of the step response. This delay was associated with the use of multiple anticipatory 
postural adjustments and/or the use of a base-width neutral step as the first step in the response. Further 
 
iv 
 
study should examine the progression of impairment in these compensatory responses across PD severity 
levels, and the correlation with fall risk.   
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CHAPTER ONE:  INTRODUCTION 
Background and Motivation 
 Parkinson’s disease (PD) is a neurodegenerative disorder estimated to affect about 350,000 
people in the United States and about 4.5 million in the world (Olanow, Stern, & Sethi, 2009). Postural 
instability leading to falls is one of the most disabling symptoms of Parkinson’s disease and greatly 
increases the risk of falling- so much that up to 70% of people with PD fall in a given year (Wood, 
Bilclough, Bowron, & Walker, 2002). Falls have devastating effects on quality of life including fractures, 
hospitalization, loss of independence, and restriction of activities (Bloem, van Vugt, & Beckley, 2001; 
Gray & Hildebrand, 2000; Lachman et al., 1998; Pickering et al., 2007; Tinetti, de Leon, Doucette, Baker, 
& Dorothy, 1994). Interventions to reduce fall risk are most effective if they are implemented before 
someone falls, but the current clinical assessments for postural instability in PD are not sensitive enough 
to track the development of postural instability prior to a fall (Munhoz et al., 2004; Visser et al., 2003). 
While progress has been made in identifying clinical and physiological parameters that can more 
accurately predict fall risk (Duncan et al., 2012; Kerr et al., 2010; King, Priest, Salarian, Pierce, & Horak, 
2012; Latt, Lord, Morris, & Fung, 2009), there is still a need to assess postural instability throughout the 
disease progression so that appropriate interventions can be introduced at appropriate times. Laboratory-
based experiments may provide the missing link in fall-risk factor development.   
It is well established that falls occur for multi-factorial reasons due to the complex interplay of 
multiple balance systems, medications and physiological changes, and musculoskeletal strength and range 
of motion. As of 2007 however, no one had developed any fall risk assessment tool that predicted falls 
any better than a history of falls (Bloem, Grimbergen, Cramer, Willemsen, & Zwinderman, 2001; 
Pickering et al., 2007). More recently, exciting advances have been made in the development of more 
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comprehensive fall risk assessment tools and the addition of more sensitive laboratory based 
measurements are clearly important in this development. 
Clinical assessment of postural instability is done with the retropulsion test. In this test, which is 
part of the United Parkinson’s Disease Rating Scale (UPDRS) evaluation, the clinician provides a sudden 
backwards pull to the patients’ shoulders and visually assesses the resulting balance response. Issues 
associated with this test include problems with reliability in executing and a lack of sensitivity in scoring 
the test, and it is not predictive of fall risk (Bloem, Grimbergen, et al., 2001; Horak, Dimitrova, & Nutt, 
2005; Robinson et al., 2005; Visser et al., 2003).   
Recently, more quantitative laboratory tests have shown promising results in detecting postural 
instability earlier in the progression of PD. In fact, a recent prospective study showed that measures of 
anterior-posterior sway while standing on a firm and foam surface was the only measure among a wide 
variety of demographic, clinical, and disease-specific tests that discriminated new fallers who fell for the 
first time in the 6 month study period (Kerr et al., 2010). This exciting development confirms the idea that 
balance-related biomechanical parameters are important in describing postural instability early in disease 
progression.  
Specific Aims 
The long-term goal of this work is to contribute towards the development of quantitative clinical 
assessments for postural instability and fall risk that effectively predict potential falls prior to a patient’s 
first fall. In our previous study, we have demonstrated that balance recovery parameters, based on the 
biomechanical analysis of body segment kinematics, kinetics, and muscle activities during the response to 
a balance disturbance, show promise in effectively detecting early signs of postural instability in those 
with mild PD (McVey et al., 2009), a group which by definition has no clinically detected postural 
instability. Further research is needed to investigate whether or not these balance recovery parameters are 
sensitive to disease progression and fall history and useful in assessing fall risk.  
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The primary goal of this work is to investigate the relationship between postural control and 
moderate PD. The first study investigates the overall response to a balance disturbance in moderate PD, 
looking at strategy, temporal, kinematic, and center of pressure parameters during the first step in the 
response. The second study further investigates this response by focusing on the center of pressure 
movement and the use of anticipatory postural adjustments during the preparation phase of the response.  
The third study investigates the use of a base-width neutral step as the first step in the response in the PD 
participants, and the effects of this strategy on balance recovery.  
Dissertation Content 
This document contains six chapters. Chapter 1 consists of an introduction to the area of study. 
Chapter 2 consists of an extensive background survey of relevant literature published. Chapter 3 consists 
of a manuscript reporting the background, methods, and results of the study investigating the effects of 
moderate Parkinson’s disease in the step response to a backwards pull. Chapter 4 consists of a manuscript 
reporting the background, methods, and results of the study investigating the effects of moderate 
Parkinson’s disease on the preparation phase of the step response. Chapter 5 consists of a manuscript 
reporting the background, methods, and results of the study investigating the effects of the use of a base-
width neutral step on balance recovery in moderate PD. Chapter 6 consists of a summary of this body of 
work.  
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CHAPTER TWO:  BACKGROUND 
Parkinson’s Disease 
Parkinson’s disease (PD) is a neurodegenerative disorder first described by James Parkinson in 
1817 and is estimated to affect about 350,000 people in the United States and about 4.5 million in the 
world (Olanow, Stern, & Sethi, 2009). These numbers are expected to rise to between 8.7 – 9.3 million 
people in the world in 2030 (Dorsey et al., 2007). PD is more prevalent in men than women, and its 
prevalence increases with age.  There are currently no other risk factors or accurate predictors of who is at 
risk, although it has been shown to have a higher prevalence rate in developed countries. It is well 
accepted that both genetic components and environmental factors contribute to the likelihood of 
developing PD (Wirdefeldt, Adami, Cole, Trichopoulos, & Mandel, 2011), although the evidence is 
varied as to which factors and what role they play in disease development. PD progressively affects 
mobility and independence, ultimately resulting in an increase in mortality rate of 2-5 times (Louis, 
Klatka, Liu, & Fahn, 1997). Current drug therapies help patients deal with the symptoms of PD, but there 
is no treatment that slows or stops the progression of the disease.  
Diagnosis. Diagnosis for PD is given through examination by a neurologist or movement 
disorders specialist. The presence of a resting tremor, asymmetry of symptoms, and a positive response to 
Levodopa therapy are an indication of the presence of Parkinson’s disease. Physiologically, PD is 
characterized by the progressive death of dopaminergic neurons in the basal ganglia, specifically in the 
pars compacta of the substantia nigra (Hickey & Stacy, 2011). It is estimated that 60-70% of these 
neurons have already been lost at the onset of symptoms (Lang & Lozano, 1998b). 
Severity Rating Scales. Parkinson’s disease is a progressive disease, and there are two severity 
rating scales currently in use to quantify its progression: The Unified Parkinson’s Disease Rating Scale 
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(UPDRS) and the Hoehn and Yahr scale. The Hoehn and Yahr scale was developed in 1967 by Margaret 
M. Hoehn, MD and Melvin D. Yahr, MD.  The Hoehn and Yahr scale consists of 5 stages to assess the 
degree of disability due to Parkinson’s symptoms (Hoehn & Yahr, 1998): 
Stage 1:  Unilateral involvement, minimal or no functional impairment. 
Stage 2:  Bilateral or midline involvement, without impairment of balance. 
Stage 3:  First sign of impaired righting reflexes possibly seen as unsteadiness as the 
patient turns, or loss of balance when pushed from standing with eyes closed and 
feet together. Functionally restricted in activities, possibly still able to work, 
physically capable of being independent, disability is mild to moderate. 
Stage 4:  Fully developed, severely disabling disease; patient is still able to walk and stand 
unassisted but is markedly incapacitated. 
Stage 5:  Confinement to bed or wheelchair unless aided. 
The Unified Parkinson’s Disease Rating Scale was developed in 1987 and consists of 3 sections: 
a mentation, behavior and mood section; an activities of daily living section; and a motor section.  In each 
section, the examiner scores the patient on a scale of 0-4 on several questions, with 0 being normal and 4 
representing the worst possible case for that question. The motor section consists of questions for the 
patient as well as several quick physical tests such as finger taps, rising from a chair, a postural stability 
test (called the retropulsion test or pull test), and rigidity tests where the examiner passively moves the 
limbs to assess rigidity. The scores for each question are added to determine the total score, with the 
maximum being 200. Scores are not typically given to the patient, but are used by the clinicians to track 
the progression of the disease.  
Pathophyisology 
Anatomy of the Basal Ganglia. The basal ganglia are located beneath the cerebral cortex and 
consist of five nuclei: the globus pallidus, caudate nucleus, putamen, subthalamic nucleus, and substantia 
nigra. The globus pallidus is divided into an internal and external region, and the substantia nigra is 
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divided into two regions: the dorsal (pars compacta) and ventral (pars reticulata) regions.  The caudate 
nucleus and putamen are often referred to together as the striatum (Kandel, Schwartz, & Jessell, 2000; 
Latash, 1998). 
Function of the Basal Ganglia. The basal ganglia are thought to be indirectly involved in 
movement by both the facilitation (allowing) and the inhibition (disallowing) of movement, perhaps in the 
role of focusing movements through the balance of facilitation and inhibition (Wichmann, DeLong, 
Guridi, & Obeso, 2011). For a movement to occur agonist muscles must be sufficiently activated and the 
antagonist muscles must be inhibited. The basal ganglia are also important in preparing the body for 
Figure 2-1.  Abnormalities in neural activity in Parkinson’s Disease. 
Notice that abnormalities in activity in basal ganglia structures lead to 
increased inhibitory activity in the thalamus, leading to decreased excitatory 
input to the cerebral cortex and suppression of the motor cortical areas. Thal: 
thalamus; GPi/GPe: globus pallidus internal/external; SNr/Snc: substantia 
nigra pars reticulata/pars compacta; Sub. Thal: subthalamic nucleus. Plus (+) 
indicates excitatory connection, minus (-) indicates inhibitory connection. In 
right figure, bold black lines indicate increased activity, thin lines indicate 
reduced activity. Figure courtesy of Dr. Paul Cheney.  
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voluntary movement as they process information needed for planning, initiating, and organizing the 
postural adjustments prior to movement, and are also involved in sequencing movements and motor 
learning (Kandel et al., 2000; Latash, 1998). Finally, the basal ganglia are thought to be involved in 
adjusting an in-process movement to an unexpected event (Marsden & Obeso, 1994; Wichmann et al., 
2011).  
Neurophysiology of the Basal Ganglia. While the basal ganglia use several neurotransmitters, 
they contain 80% of the total dopamine in the brain. Parkinson’s disease is caused by the death of these 
dopaminergic neurons that project between the striatum and the substantia nigra pars reticulata (Kandel et 
al., 2000; Latash, 1998). Loss of these projections causes increased activity in subthalamic nucleus 
neurons which leads to suppression of thalamic activity, ultimately leading to suppression of cortical 
motor areas. By the onset of symptoms in Parkinson’s disease, 60-70% of the dopaminergic projections 
have been lost in the ventrolateral tier of substantia nigra pars compacta (Lang & Lozano, 1998a). Figure 
2-1 illustrates the basal ganglia circuitry and what is different in Parkinson’s disease.  
The basal ganglia receive input at the striatum from the cerebral cortex, thalamus, and brain stem. 
Output from the basal ganglia leaves from the globus pallidus internal (GPi) region or the substantia nigra 
pars reticulata (SNr) region (Wichmann et al., 2011). The main output is to the cerebral cortex via the 
thalamus although it also outputs to the brain stem. The basic basal ganglia-thalamo-cortical loop consists 
of input from cerebral cortexstriatum GPi and/or SNr output to thalamus. All output from the basal 
ganglia is inhibitory. This loop is somatatopically organized, so that certain parts of the cortex project to 
certain parts of the striatum (Kandel et al., 2000; Latash, 1998).  
There are thought to be two main pathways through the basal ganglia. The direct pathway is 
thought to facilitate movement through the inhibition of the GPi and SNr neurons, which results in 
reduced inhibition of thalamocortical projections, and the facilitation of movement. The indirect pathway 
is thought to suppress movement by increasing the inhibitory output of the basal ganglia.  There is 
another pathway called the hyperdirect pathway, which also results in increased inhibitory output and 
suppressed movement, however this loop works faster than the indirect pathway (Wichmann et al., 2011).  
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Symptoms of Parkinson’s Disease 
The loss of dopaminergic input from the substantia nigra pars reticulata causes increased activity 
in the indirect pathway (which inhibits movement) and decreased activity in the direct pathway (which 
facilitates movement). Both of these situations lead to decreased activity of the motor cortex, leading to 
the common symptoms of Parkinson’s disease. 
Bradykinesia. Bradykinesia refers to slowed and sometimes incomplete movements.  Akinesia 
refers to a failure of willed movement to occur (Hallett, 2003). Bradykinesia is physiologically defined as 
a failure to energize muscles to a level sufficient to complete a movement in a reasonable amount of time, 
and movement is especially slow in sequenced movements. Akinesia is physiologically defined as a 
prolongation of reaction time- a muscle is selected but not activated, especially seen in initiating 
voluntary movement (Hallett, 2003).  In PD, bradykinesia and akinesia are seen in the expressionless 
appearance of the face, shuffling gait, and difficulty initiating movements (Latash, 1998). These are 
thought to be due to the loss of the dopaminergic neurons in the direct pathway, resulting in increased 
inhibition of the motor cortex (Kandel et al., 2000; Latash, 1998). 
Tremor and Rigidity. Parkinson’s disease is characterized in part by a resting tremor at about 4-6 
Hz. Rigidity is manifested as an increased muscle tone resulting in resistance to passive movements. 
These are examples of abnormal motor activation due to input from affected projections in the indirect 
pathway (Hallett, 2003; Kandel et al., 2000; Latash, 1998). Physiologically, rigidity can be caused by a 
change in muscle properties or joint characteristics, the amount of background contraction of the muscles, 
and the magnitude of the stretch reflex. In PD all three are affected (Hallett, 2003). 
Postural Instability. Postural instability refers to the impaired balance and coordination often seen 
in those with Parkinson’s disease. Postural stability requires proper sensory organization, appropriate 
motor adjustments to prepare, execute, and adjust a movement, and appropriate background muscle tone 
(Horak, Nutt, & Nashner, 1992b). Patients with PD often have abnormal postural preparations prior to a 
voluntary movement, have increased sway when standing still, use abnormal and ineffective postural 
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reactions to an external perturbation, and are less able to adapt a postural response to a change in support 
or environmental conditions (Burleigh-Jacobs, Horak, Nutt, & Obeso, 1997; Chong, Horak, & 
Woollacott, 2000; Horak et al., 1992b; King, St George, Carlson-Kuhta, Nutt, & Horak, 2010; Nutt, 
Horak, & Bloem, 2011). Postural instability combined with other PD symptoms leads to an increased risk 
of falling in those with Parkinson’s disease.   
Therapy 
There are currently no treatments that have been shown to slow or stop the progression of 
Parkinson’s disease. However, therapies do exist that improve the motor complications associated with 
the disease. 
Levodopa and Drug Therapy. Levodopa is still the most effective drug therapy for PD.  
Introduced over 40 years ago, Levodopa is a dopamine therapy, working to replace dopamine that has 
been lost in the brain. Levodopa reduces the severity of PD symptoms such as bradykinesia, rigidity and 
tremor, and is effective initially in over 90% of patients (Lang & Lozano, 1998a, 1998b).  
While Levodopa is very effective early on in disease progression, complications begin as its use 
becomes more long-term. Complications such as dyskinesias, motor fluctuations (responding normally to 
the medication for a period, followed by periods of minimal response), and wearing off occur in about 
50% of patients who use the drug for 5 years or more, and in about 80% of patients who use the drug for 
10 years (Hickey & Stacy, 2011; Koller & Tse, 2004). 
Another concern is that several symptoms of PD do not respond to Levodopa treatment. In 
particular, motor deficits such as postural instability, freezing of gait, and swallowing problems have been 
shown to be resistant to Levodopa treatment (Bronte-Stewart, Minn, Rodrigues, Buckley, & Nashner, 
2002; Koller & Tse, 2004). In a postural sway study by Rocchi et al. it was shown that Levodopa 
treatment actually increased abnormalities in sway, and subjects performed better when off medication 
(Rocchi, Chiari, & Horak, 2002). In addition, in a study on the effects of Levodopa, subjects receiving the 
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highest dose had significantly more dyskinesia, hypertonia, infection, headache, and nausea as compared 
to controls on placebo (Fahn et al., 2004). 
Other types of drug therapies are being used to treat PD as well. Non-dopaminergic therapies 
such as Adenosine A2A Agonists and Monoamine Oxidase B inhibitors help to reduce the side-effects of 
Levodopa and show potential neuroprotective effects, respectively (Hickey & Stacy, 2011). Dopamine 
agonists are also used and have less risk of motor fluctuations but a higher incidence of side effects 
(Hickey & Stacy, 2011).  
Deep Brain Stimulation. Deep Brain Stimulation (DBS) has become a very effective alternative to 
Levodopa therapy for treating PD. In fact, it is more effective at treating motor problems and improving 
quality of life in patients with motor fluctuations (Weaver et al., 2009). This treatment involves high 
frequency stimulation through electrodes placed most often in the subthalamic nucleus or globus pallidus 
internal of the basal ganglia. More recently, stimulation of the pedunculopontine nucleus has been 
discovered as a target to improve postural instability (Hickey & Stacy, 2011). The advantages over 
Levodopa therapy most likely stem from the fact that DBS can affect non-dopaminergenic pathways, 
which are thought to be increasingly affected by Parkinson’s disease (Rocchi, Chiari, Cappello, Gross, & 
Horak, 2004). However, only about 5% of PD patients meet the criteria to be eligible for DBS (clinically 
diagnosed idiopathic PD, experiencing disabling motor fluctuations, no signs of dementia, and currently 
responsive to Levodopa treatment), so it is not a widespread therapy (Hickey & Stacy, 2011).  
Postural Instability 
Postural control is described by the center of mass, center of pressure, and base of support. The 
center of pressure is the point where the resultant ground reaction force for the body acts. The base of 
support is the area circumscribed by the support surface (the feet when standing). The center of pressure 
changes constantly to account for the change in location of the center of mass. For stability, the center of 
mass should not leave the base of support, so the center of pressure constantly moves around to keep the 
center of mass within the base of support (Latash, 1998).   
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The brain receives and processes different types of cues about the position of the body and its 
stability from several different systems. The vestibular system provides signals related to the orientation 
and movement of the head in space via organs in the inner ear. The somatosensory system provides 
signals gathered from the skin and deep pressure sensors in the body and includes touch, pain, pressure, 
temperature, and proprioception (Buchanan & Horak, 2003; Latash, 1998). Visual information is another 
source of postural information. Postural stability requires the proper processing of information from all of 
the sensory systems, appropriate motor adjustments to prepare, execute, and adjust a movement, and 
appropriate background muscle tone (Horak, Nutt, & Nashner, 1992a). 
Falls in Parkinson’s Disease. Falls have a devastating impact on quality of life and Parkinson’s 
disease greatly increases the risk of falling. The 3 month fall rate is almost 50% in PD (Pickering et al., 
2007), and the yearly fall rate has been estimated to be as high as 70% (Wood, Bilclough, Bowron, & 
Walker, 2002). This is significant because falls have devastating effects on quality of life including 
fractures, hospitalization, loss of independence, and restriction of activities (Bloem, van Vugt, & Beckley, 
2001; Gray & Hildebrand, 2000; Lachman et al., 1998; Pickering et al., 2007; Tinetti, de Leon, Doucette, 
Baker, & Dorothy, 1994).   In a retrospective study of 1,092 Parkinson’s patients by Wielinski et al., 65% 
of those who fell sustained an injury, 22% of those who fell sustained a fracture, and 41% of those 
sustaining fractures required surgery. Notably, 27% of the entire study group required health care services 
as a result of falling. This indicates substantial costs associated with falling in Parkinson’s disease 
(Wielinski, Erickson-Davis, Wichmann, Walde-Douglas, & Parashos, 2005). Other studies have echoed 
this increased risk of falling and increased risk of injury in Parkinson’s disease (Balash et al., 2005a; 
Contreras & Grandas, 2012). In addition to the severe consequences of injurious falls, a fear of falling 
(with or without a previous fall) has been shown to be associated with increased fall risk as well as 
indicating a reduced quality of life in older adults (Adkin, Frank, & Jog, 2003; Mak & Pang, 2009; Tinetti 
et al., 1994).      
Fear of Falling. Fear of falling is even more prevalent in Parkinson’s disease than in the general 
elderly population and may or may not stem from actually experiencing a fall (Adkin et al., 2003; Tinetti 
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et al., 1994). This fear can have a significant impact on quality of life as well as on the risk of falling. In 
addition to added general stress, fear of falling impacts quality of life by causing the person to restrict 
physical and social activities in which they would normally participate (Tinetti et al., 1994). Tinetti et al. 
developed the Falls Efficacy Scale in order to more precisely determine the relationship between fear of 
falling and actual functioning. They found that falls efficacy was strongly associated with tests of 
functioning and that a person’s perception of capability influences behavior, regardless of the actual 
capability. In addition, they found that about 15% of subjects who had never fallen reported a decrease in 
activity due to a fear of falling, indicating an unnecessary decline in quality of life (Tinetti et al., 1994).  
In addition to the quality of life impacts, fear of falling has also been associated with an increase 
in fall risk, especially in Parkinson’s disease (Bloem, Steijns, & Smits-Engelsman, 2003; Evitt & Quigley, 
2004; Mak & Pang, 2009; Murphy, Dubin, & Gill, 2003; Robinson et al., 2005). This may be due to the 
decrease in activity, a change in postural stability due to increased caution, or a change in balance 
strategy. The exact interaction between fear of falling and postural instability is still unknown.  
Assessment of Fall Risk in PD.  It is well established that falls occur for multi-factorial reasons 
due to the complex interplay of multiple balance systems, medications and physiological changes, and 
musculoskeletal strength and range of motion. Previously, multiple studies have determined several 
individual factors that are associated with an increased risk of falling in PD- specifically a history of 
previous falls, increased disease severity and duration, depression, dementia, and urinary incontinence 
(Ashburn, Stack, Pickering, & Ward, 2001; Balash et al., 2005b; Bloem et al., 2003; Gray & Hildebrand, 
2000; Wood et al., 2002). In addition, the following factors have also been associated with a history of 
falls: the presence of dyskinesias, freezing episodes, loss of arm swing, fear of falling, poorer scores on 
several measures of the UPDRS test, poor performance on clinical measures of motor planning, fine 
motor control, limb coordination, and gait (Ashburn et al., 2001; Balash et al., 2005b; Dennison et al., 
2007; Gray & Hildebrand, 2000; Matinolli et al., 2007; Robinson et al., 2005; Wood et al., 2002). As of 
2007 however, no one had developed any fall risk assessment tool that predicted falls any better than a 
history of falls (Bloem, Grimbergen, Cramer, Willemsen, & Zwinderman, 2001; Pickering et al., 2007). 
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More recently, exciting advances have been made in the development of more comprehensive fall risk 
assessment tools and the addition of more sensitive laboratory based measurements are clearly important 
in this development. 
Laboratory-based experiments may provide the missing link in fall-risk factor development, as a 
recent study demonstrated the postural sway component of a clinical balance test  to be the only measure 
among a wide variety of clinical tests that was significantly different between a group of non-fallers with 
PD and a group of previous non-fallers with PD who experienced their first fall in the 6 month study 
period (Kerr et al., 2010). In addition, the recently developed Balance Evaluation Systems Test 
(BESTest), the most comprehensive evaluation available to date, includes components derived from 
laboratory sway and balance tests (Horak, Wrisley, & Frank, 2009). 
The (BESTest) was recently proposed by Horak et al. as a comprehensive fall risk assessment 
tool (Horak et al., 2009). This is a clinical test that evaluates 6 different balance components: 1) 
Biomechanical Constraints (base of support, center of mass alignment, ankle strength and range of 
motion, hip/trunk lateral strength, sit on floor and stand up), 2) Stability Limits/Verticality (sitting 
verticality and lateral lean, functional reach forward, functional reach lateral), 3) Anticipatory Postural 
Adjustments (sit to stand, rise to toes, stand on one leg, alternate stair touching, standing arm raise), 4) 
Postural Responses (feet-in-place response forwards and backwards, compensatory stepping, backwards 
and lateral), 5) Sensory Organization (sensory integration for balance test- evaluating sway during stance 
on a firm surface with eyes open and eyes closed, and stance on a foam surface with eyes open and eyes 
closed), and 6) Stability in Gait (level surface gait, change in gait speed, walking with head turns, walking 
with pivot turns, stepping over obstacles, “Timed Up and Go” test, “Timed Up and Go” test with dual 
task).  
 The advantages of this test are that it not only evaluates several of the different types of balance 
impairments that may exist and lead to falls, it can also give physical therapists direction as far as where 
to focus therapies to improve balance and reduce fall risk. It has been shown to be more sensitive than the 
Berg Balance Scale and the Functional Gait Assessment (Leddy, Crowner, & Earhart, 2011), and to be 
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effective at identifying fallers within 6 months of a fall, but not at 12 months (Duncan et al., 2012). The 
disadvantages of this test are that it is time intensive- it takes a full 30 minutes for a trained physical 
therapist to administer the test, and some of the evaluation points such as “sway on a hard surface” are  
hard to visually measure outside of a laboratory (Horak et al., 2009). This test scores each component on 
a scale from 0 (worst) to 3 (best). This is by far the most comprehensive balance assessment tool available 
however, it was really designed for the physical therapist to use in determining specific balance training 
for individuals. There is still a need for a more diagnostic fall risk tool that will allow clinicians to refer 
patients at certain levels of fall risk to see a physical therapist and begin the more intense balance 
assessments.   
Assessment of Postural Instability. Postural instability is one of the cardinal symptoms of 
Parkinson’s disease and ultimately leads to falls (Michalowska, Fiszer, Krygowska-Wajs, & Owczarek, 
2005). The retropulsion test (sometimes called the pull test) is widely used to assess postural instability in 
Parkinson’s disease. In this test, which is part of the United Parkinson’s Disease Rating Scale (UPDRS) 
evaluation, the clinician provides a sudden backwards pull to the patient’s shoulders and visually assesses 
the resulting balance response. Problems associated with this test include problems with reliability in 
executing and scoring the test. For example, some examiners warn patients about the pull and perform it 
several times, while others provide no warning and perform it only once. The patient’s response is scored 
on a course scale of 0-4 defined as follows: 0: normal, 1: recovers unaided, 2: would fall if not caught, 3: 
unstable, loses balance spontaneously, 4: unable to stand unassisted. The rating scale does not have a 
specific definition of a normal response or a cutoff response that indicates high fall risk. It is implied that 
those at a higher risk of falling require more steps to maintain their balance, while those at a lower risk 
require fewer steps. This test has been shown to be sensitive to differences between PD patients with and 
without a history of falls, however most of those studies involve severe cases of PD who already exhibit 
major balance problems and it is not predictive of fall risk (Bloem, Grimbergen, et al., 2001; Horak, 
Dimitrova, & Nutt, 2005b; Robinson et al., 2005; Visser et al., 2003).  
 
25 
Recently, more quantitative laboratory tests have shown promising results in detecting postural 
instability earlier in the progression of PD. One study of 55 subjects with mild-moderate PD showed that 
an increased medial-lateral sway and increased sway area were associated with increased postural 
instability as rated by the H&Y and UPDRS (Blaszczyk, Orawiec, Duda-Klodowska, & Opala, 2007). 
Another study of 215 PD patients found that an increased sway area was an independent risk factor for 
recurrent falling in PD (Matinolli et al., 2007). More recently, a prospective study showed that measures 
of AP sway while standing on a firm and foam surface (as part of the PPA- Physiological Profile 
Assessment) was the only measure among a wide variety of demographic, clinical, and disease-specific 
tests that discriminated NEW fallers- fallers who fell for the first time in the 6 month study period (Kerr 
et al., 2010). This exciting development confirms the idea that balance-related biomechanical parameters 
are important in describing postural instability early in disease progression.  
Balance Recovery 
The ability to recover balance after an unexpected perturbation is essential to preventing a fall. 
Studies have shown that with age and certain pathologies, strategies for balance recovery change. When 
presented with a balance perturbation there are two types of responses. A fixed-support response is when 
balance is recovered without moving the base of support. Included in this category are the ankle and hip 
response strategies, which involve rotating at the ankle or hip to maintain balance without moving the 
base of support. A change-in-support response is evoked when the perturbation is large enough that the 
fixed-support responses are not as effective. This usually involves changing the location and 
configuration of the base of support. A stepping response often requires the use of an anticipatory postural 
adjustment, where the body weight is shifted to the stance limb prior to liftoff of the stepping limb (Maki, 
McIlroy, & Fernie, 2003).  
Differences in the stepping response have been widely studied in elderly subjects, who also have 
an increased risk of falling. Older adults tend to resort to a stepping strategy at smaller disturbances than 
young adults. They tend to take multiple, shorter steps, and tend to step laterally in response to an anterior 
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or posterior perturbation (Hall & Jensen, 2002; Luchies, Alexander, Schultz, & Ashton-Miller, 1994; 
McIlroy & Maki, 1996; Schulz, Ashton-Miller, & Alexander, 2005). In addition, they show larger peak 
ankle and hip torque and power (Madigan, 2006; Madigan & Lloyd, 2005a), reductions in hip flexion, 
knee flexion and extension, and ankle plantarflexion velocity (Madigan & Lloyd, 2005b). Elderly subjects 
with a history of falls showed smaller peak ankle torque, slower reaction time, and slower rate of ankle 
torque development in response to a forward lean and release perturbation (Mackey & Robinovitch, 
2005), and also tended to step laterally in response to a backwards pull (Schulz et al., 2005).  
Studies have investigated balance recovery in Parkinson’s disease. The majority of these studies 
have involved subject populations with moderate to severe PD and often off medications. In fact, several 
studies have specifically chosen their subject population because of difficulties with balance (Chong et 
al., 2000; Dimitrova, Horak, & Nutt, 2004; Dimitrova, Nutt, & Horak, 2004; Horak, Dimitrova, & Nutt, 
2005a; Horak, Frank, & Nutt, 1996; Horak et al., 1992b). These studies have been helpful in determining 
which aspects of balance are affected by PD. For instance, PD introduces abnormal foot-floor reaction 
forces, muscle activation patterns, and inflexibility in the feet-in-place response to surface translations 
(Dimitrova, Horak, et al., 2004; Dimitrova, Nutt, et al., 2004; Horak et al., 1992b), but this information 
does not help us understand how balance problems progress with disease progression. 
The step response to a balance perturbation has also been investigated in Parkinson’s disease. 
Jacobs et al. have found that moderate and severe PD subjects show differences in response compared to 
healthy controls. They use shorter than normal steps, use multiple anticipatory postural adjustments, have 
a longer step foot liftoff time, and are less consistent in the choice of stepping limb in the response to a 
backwards surface translation. This altered response may be due to an inability to quickly select an 
appropriate response since young exhibit similar behavior when they are unable to pre-select the stepping 
foot (Jacobs & Horak, 2006a, 2006b; King et al., 2010).   
Kinematic and kinetic studies during functional tasks in persons with PD have shown significant 
differences in those parameters during gait, step initiation, and sit-to-stand tasks. In gait, moderately 
affected PD subjects on medication showed smaller ankle range of motion during the push off and swing 
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phases, and smaller peak plantarflexion at toe off and in the swing phase (Sofuwa et al., 2005). In gait 
initiation, moderate to severely affected PD subjects off medication showed decreased force production, 
decreased velocity, and slowed execution of anticipatory postural adjustments (Burleigh-Jacobs et al., 
1997), while mild and moderate patients showed decreased COM-COP distances, indicating worse 
dynamic stability (Hass, Waddell, Wolf, Juncos, & Gregor, 2008). In a sit-to-stand task, moderately 
affected PD subjects on medication showed smaller hip flexion torque and slower time to peak torque in 
the ankle, knee, and hip (Mak, Levin, Mizrahi, & Hui-Chan, 2003), and reduced ability to sequence two 
tasks in a sit-to-walk test (Buckley, Pitsikoulis, & Hass, 2008). The differences in kinetics and kinematics 
during functional tasks may describe certain deficiencies that put the PD population at a higher risk of 
falling, but these differences during balance recovery are less understood.   
It is important to note that until recently, studies in Parkinson’s disease have investigated the step 
response only late in the disease progression when postural instability is already clinically recognized. 
Recently, however, it was demonstrated that even those with mild PD (H&Y II- no fall history or clinical 
indication of postural instability) showed impairments in the step response to a backwards pull (McVey, 
et al., 2009). PD participants, compared to healthy controls, took longer to liftoff for the first step, used 
different ankle kinematics during the step, and their center of pressure was further back at landing. 
Further research is needed to examine how these changes progress with a progression in disease severity.   
 Since interventions exist for those at increased risk of falling, and the consequences of even one 
fall are severe, it is important to determine the appropriate time to begin an intervention targeting fall risk, 
prior to the first fall event.  
Anticipatory Postural Adjustments: 
In order to preserve stability when taking a step, a person must shift their weight to the stance 
foot prior to lifting off with the swing foot for the step. It is well-established that during voluntary tasks 
such as gait initiation, an anticipatory postural adjustment (APA) is used in order to help propel the center 
of mass (COM) towards the stance foot. An APA is characterized as a vertical loading and then unloading 
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of the swing foot, resulting in a medial-lateral shift in the COP towards the swing leg (McIlroy & Maki, 
1993). During external perturbations, these APAs are not as characteristically seen, and even when they 
are present they are not effective in propelling the COM towards the stance foot (McIlroy & Maki, 1993, 
1999).   
Investigation of the control of the center of pressure during the response to a balance disturbance 
has shown significant differences between those with PD compared to healthy controls, particularly in the 
step initiation phase. In our previous study (McVey, et al., 2009), most differences between mild PD and 
healthy controls occurred prior to liftoff of the first step, which implies that after liftoff the characteristics 
of the step were similar between the two groups. Further investigation of this phase of the response and 
the center of pressure showed that some of the PD patients were using multiple anticipatory postural 
adjustments (APAs) prior to liftoff (McVey, et al., 2008). Another recent study has shown that patients 
with Parkinson’s disease use APAs more frequently than healthy controls (King et al., 2010), and that the 
use of an APA results in later liftoff times, and the use of significantly more and shorter steps to regain 
balance. In addition, the PD participants sometimes used multiple APAs- a much less effective response- 
when healthy controls never used more than one APA. This study included a large range of severity levels 
within the PD group, so the relationship between postural instability and PD severity level remains 
unclear.  
In order to better understand the use of multiple APAs in PD patient, Jacobs investigated the use 
of APAs in healthy young subjects in response to external predictable and unpredictable perturbations 
(Jacobs & Horak, 2007). They defined an APA as a lateral weight shift preceding a step and measured it 
from the lateral displacements of the COP that occurred between onset of the disturbance to toe off of the 
stepping foot. In the unpredictable condition, young subjects sometimes used multiple APAs 
(approximately 30% of the trials showed multiple APAs compared to 70% with only one APA in the 
unpredictable condition). In the unpredictable condition, APA onset latencies and durations were longer. 
In addition, the onset latencies and durations were longest in the cases when subjects used multiple APAs.  
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Lateral Stability 
Impairments in lateral stability have been shown to be associated with aging, falls, and PD in the 
step response to a balance disturbance. Older adults tend to use a crossover strategy where younger adults 
take a side step. In addition, older adults typically take more steps and take longer and larger initial steps, 
(Mille, Johnson, Martinez, & Rogers, 2005). In response to forwards or backwards perturbations, older 
adults with a history of falling show reduced lateral stability. For instance, older adults often direct later 
steps of a multiple step response to a forwards or backwards disturbance more laterally than young 
(McIlroy & Maki, 1996). 
Differences between fallers and non-fallers seem to be most prevalent in the liftoff to landing 
stage of the response. The initial characteristics of the step prior to liftoff are similar, but by landing 
fallers have moved farther sideways and with greater velocity, and the location of the step is more lateral. 
Older fallers also tend to have a longer step duration, earlier liftoff time, and direct their initial step more 
laterally compared to older non-fallers (Rogers, Hedman, Johnson, Cain, & Hanke, 2001). In addition to 
balance recovery, a wider step width during gait has been shown to be associated with experiencing a fall 
within 1 year (Maki, 1997).  
Patients with Parkinson’s disease have shown an increase in lateral sway during a quiet stance 
test (Mitchell, Collins, De Luca, Burrows, & Lipsitz, 1995), and reduced lateral stability in leaning 
balance tests (Menant, Latt, Menz, Fung, & Lord, 2011; van Wegen, van Emmerik, Wagenaar, & Ellis, 
2001). However, the effect of both PD and PD disease severity on lateral stability during the response to a 
balance disturbance is not well understood.  
Estimation of the Center of Mass 
Quantifying the motion of the center of mass is essential in quantifying lateral stability, as well as 
other components of balance recovery. Several methods exist to estimate the center of mass. The 
kinematic method involves estimating the center of mass of several body segments, and then directly 
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calculating the center of mass using equation     
 
 
 ∑     , where M is the total mass of the body, 
mi is the segment mass, and ri is the segment center of mass (Winter, Patla, Prince, Ishac, & Gielo-
Perczak, 1998). Another method is based on Newton’s law,  ⃗    ⃗. The position of the center of mass is 
approximated by double integration of the lateral ground reaction forces read from a force platform using 
the following equations:  ⃗   
 
 
⃗⃗⃗
  ⃗  ∫  ⃗     ⃗   ∫  ⃗   , where a = acceleration, v = velocity, p = 
position, F = ground reaction forces, and m= total mass of the body (Lafond, Duarte, & Prince, 2004; 
Shimba, 1984; Zatsiorsky & King, 1998). The constants of integration are the initial position and initial 
velocity of the center of mass. These are commonly assumed to be zero, if the experimental setup can 
justify such an assumption. Alternatively, methods such as “zero-point-to-zero-point” integration are used 
to get a more accurate value for the initial velocity (Zatsiorsky & King, 1998); however this is based on 
the assumption that whenever the lateral ground reaction forces are zero, the COM and COP coincide, 
which is a good assumption in static tasks such as postural sway, but not in dynamic tasks such as balance 
recovery.    
Numerical integration of real data can result in magnification of noise in the data and result in 
errors in the integration. To combat against this, often data is detrended after the first integration before 
integrating again (Gutierrez-Farewik, Bartonek, & Saraste, 2006; Whittle, 1997).   
Interventions to Reduce Fall Risk 
Effective interventions exist for those at high risk of falling. In the healthy elderly population, 
multi-factorial programs together with targeted individual therapies are the most effective in fall 
prevention (Rao, 2005). These programs typically include exercise and physical therapy, gait and balance 
training, advice on proper use of assistive devices, review and modification of medications, treatment of 
postural hypotension, modification of environmental hazards, and targeted medical assessments. 
Individual interventions are then determined based on the factors most prevalent in the patient. These 
multi-factorial interventions have reduced fall risk by up to 66% (Rao, 2005).  
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A similar multi-factorial approach is probably necessary to reduce fall risk in persons with PD. 
Studies have investigated the effects of physical therapy, tai-chi, and balance and gait training on PD 
fallers, and while they have not been able to conclusively prevent falls, they have seen improvements in 
balance and gait measures (Li et al., 2012; Pohl, Rockstroh, Ruckriem, Mrass, & Mehrholz, 2003; Protas 
et al., 2005; Stankovic, 2004). Stankovic et al. studied the effect of physical therapy on balance in healthy 
elderly, PD fallers, and PD non-fallers (Stankovic, 2004). Physical therapy, including regular physical 
activity, walking with a visual stimulus, stepping, playing recreational sports, strategies for correction of 
motor function such as attention, maintaining an upright posture, and elongation of muscles, was applied 
for 30 days. Balance measures included quiet standing tasks, internal perturbation tasks, and an external 
perturbation. This study showed that the physical therapy program improved all of the balance measures, 
especially the tandem stance, single leg stance, functional reach, step, and external perturbation tests. 
While this study was not able to show the effect on falls, it did find an improvement in some of the 
measures that are used to assess fall risk.  
Other studies on gait and compensatory step training in PD have shown improvements in both 
gait and step parameters and one study showed a 50% decrease in falls in the group that received the 
intervention (Jobges et al., 2004; Protas et al., 2005). Therefore, there is reason to think that targeted 
interventions may reduce the risk of falling in persons with PD.  
Summary 
Parkinson’s disease is a debilitating disease and postural instability leading to falls is one of the 
most disabling symptoms. Experiencing a fall severely impacts quality of life on physical, economic, and 
psychological levels. While there are effective interventions that reduce fall risk, they are often not 
implemented until after the first fall due to a sensitive measure of postural instability. If laboratory or 
clinical assessments were available to identify the appropriate time to begin targeted interventions, fall 
risk could be significantly reduced. Prevention of that first fall would allow persons with Parkinson’s 
disease to maintain an independent and active lifestyle as long as possible.   
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CHAPTER THREE:  THE EFFECT OF MODERATE PARKINSON’S DISEASE ON 
COMPENSATORY BACKWARDS STEPPING 
Introduction 
Postural instability leading to falls is one of the most disabling symptoms of Parkinson’s disease 
(PD). The 3 month fall rate is estimated at 46% for the general population with PD, and 21% among those 
who have no history of falls (Pickering et al., 2007). Falls have devastating effects on quality of life 
including fractures, hospitalization, loss of independence, and restriction of activities (Bloem, van Vugt, 
& Beckley, 2001; Gray & Hildebrand, 2000; Lachman et al., 1998; Pickering et al., 2007; Tinetti, de 
Leon, Doucette, Baker, & Dorothy, 1994). Interventions to reduce fall risk are most effective if they are 
implemented before someone falls, but the current clinical assessments for postural instability in PD are 
not sensitive enough to track the development of postural instability prior to a fall (Munhoz et al., 2004; 
Visser et al., 2003). While progress has been made in identifying clinical and physiological parameters 
that can more accurately predict fall risk (Duncan et al., 2012; Kerr et al., 2010; King, Priest, Salarian, 
Pierce, & Horak, 2012; Latt, Lord, Morris, & Fung, 2009), there is still a need to understand how postural 
instability progresses so that appropriate interventions can be introduced at appropriate times. Laboratory-
based experiments may provide the missing link in fall-risk factor development.   
The response to a balance disturbance must be quick and appropriate for the disturbance and 
environmental constraints that exist. The quantitative analysis of this response has many advantages over 
purely clinical assessments. Biomechanical parameters involving force plates, EMG, and motion tracking 
systems allow for complex analysis in the determination of temporal, muscular, kinematic, and kinetic 
parameters used to quantify the response, giving information far more detailed than possible using clinical 
assessments. In fact, a study has demonstrated that increased COP movement as measured by force 
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platforms were more associated with future falls than clinical measures of balance (Pajala et al., 2008). 
Another recent study demonstrated the postural sway component of a clinical balance test to be the only 
measure among a wide variety of clinical tests that was significantly different between a group of non-
fallers with PD and a group of previous non-fallers with PD who experienced their first fall in the 6 
month study period (Kerr et al., 2010). In addition, our previous study showed that biomechanical 
measures were able to detect differences in PD patients with no clinical indication of postural instability 
(McVey et al., 2009). Using multiple biomechanical parameters, such as the center of pressure movement, 
muscle activity, kinematics, and kinetics, may provide an even stronger assessment of postural instability. 
The biomechanical analysis of the step response to a sudden balance disturbance has already 
shown to be effective in detecting differences between older adults who have an increased risk of falling 
compared to younger adults. For example, older adults use a step response at smaller disturbances, take 
multiple and shorter steps, and step more laterally in response to an anterior or posterior perturbation 
(Luchies, Alexander, Schultz, & Ashtonmiller, 1994; McIlroy & Maki, 1996; Schulz, Ashton-Miller, & 
Alexander, 2005). Studies in Parkinson’s disease have demonstrated that participants with moderate to 
severe PD, compared to healthy controls, utilize shorter steps and multiple anticipatory postural 
adjustments (APAs) in response to a backwards surface translation (Jacobs & Horak, 2006; King, St 
George, Carlson-Kuhta, Nutt, & Horak, 2010). However most studies in PD have primarily focused on 
patients who have already been clinically diagnosed with postural instability, already exhibit major 
balance deficits, and have a wide range of severity levels (H&Y II-V) (Chong, Horak, & Woollacott, 
2000; Dimitrova, Nutt, & Horak, 2004; Horak, Dimitrova, & Nutt, 2005; Horak, Frank, & Nutt, 1996a; 
Jacobs & Horak, 2006; King et al., 2010). It is not clear how postural instability progresses and how it 
relates to disease severity. In an attempt to elucidate potential biomechanical measurements that may be 
candidates for early markers of postural instability, our group recently investigated the effects of mild PD 
on the biomechanics of the step response (McVey et al., 2009). We demonstrated that those with mild PD 
(H&Y II), compared to healthy controls, took longer to liftoff for the first step, used different ankle 
kinematics during the step, and their center of pressure was further back at landing. The next step towards 
 
39 
the goal of understanding the progression of PD is to examine the effect of moderate PD on postural 
instability. The goal of this study was to determine if the same parameters that changed with mild PD 
continue to change with an increase in disease severity, so we examined the response to a balance 
disturbance in moderate PD.  
Methods 
Participants: Ten participants diagnosed with moderate PD (PD: Age 68 ± 4 years, range 61-73 
years, Height: 173 ± 10 cm, range 157-186 cm, Mass: 85 ± 19 kg, range 56-116 kg) and ten healthy age-
range matched controls (HC: Age 68 ± 5 years, range 63-79 years, Height: 175 ± 6 cm, range 170-186 
cm, Mass: 75 ± 13 kg, range 55-92 kg) completed the study (8 male and 2 female in each group). 
Exclusion criteria included dementia (MMSE score less than 24) (Folstein, Folstein, & McHugh, 1975), 
significant depression (Beck Depression Inventory > 14) (Beck, Ward, Mendelson, Mock, & Erbaugh, 
1961) and inability to ambulate without assistance. All participants gave written informed consent 
approved by the University of Kansas Medical Center (KUMC) Human Subject’s Committee. 
People diagnosed with idiopathic PD were recruited from the KUMC Parkinson’s Disease and 
Movement Disorder Center and were assessed with the Unified Parkinson’s Disease Rating Scale 
(UPDRS). Exclusion criteria included patients who had a H&Y score other than 3 (only participants with 
a H&Y score of 3 were included in this study), those who had undergone deep brain stimulation or had a 
history of significant musculoskeletal, neurological, or cognitive impairments other than those associated 
with PD were excluded. Participants with PD were instructed to maintain their normal medication 
schedule (Table 1) and were tested on the medication “ON” phase which was 2.22 ± 1.1 hours since last 
dose. Healthy controls (HC) living independently were recruited from the community. Medical history 
and a physical examination excluded those with cardiovascular, musculoskeletal and neurological 
impairments. 
Task. The participant stood with arms crossed at the chest and weight equally distributed between 
the feet. The participant also wore standardized footwear. For safety purposes, a safety harness connected 
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to an overhead support was worn by the participant and a research assistant stood nearby to help prevent 
injury in case of a fall. The participant wore an adjustable but rigid waist harness that was connected to a 
weight-drop mechanism via a cable in the back of the harness. When triggered, the weight-drop 
mechanism produced a posterior waist pull by dropping a weight (20% body weight) with a pull distance 
equal to 8.7% of waist height (Luchies, Alexander, Schultz, & Ashton-Miller, 1994). The selected pull 
magnitude was large enough to ensure that each participant used a step response to recover balance. The 
participant was instructed to respond naturally to the posterior pull, which was repeated until three good 
trials were obtained. Examples of bad trials included not stepping onto a force plate or obstructing the 
cameras' view of kinematic markers. A maximum of six trials were performed by each participant.   
Experimental Measurements: Video, motion, force plate, electromyography (EMG), and load cell 
data were collected for each trial. Motion data was sampled at 100 Hz using an Optotrak (Northern 
Digital, Inc., Waterloo, Canada) dual bar motion analysis system. Markers were placed bilaterally on the 
2
nd
 toe, ankle, heel, calf, and knee. EMG data was measured using an eight channel Delsys surface 
electrode system (Delsys, Boston, MA, USA). Electrodes were placed bilaterally on the tibialis anterior 
(TA). Foot/floor reaction forces and moments were measured using three AMTI (Advanced Mechanical 
Technology Inc.; Watertown, MA, USA) six-component force plates. A biaxial custom-built load cell was 
used to measure the tensile force in the cable attached to the waist harness. Analog data was sampled at 
1000 Hz using a 16-bit A/D data acquisition system. 
Analysis: The parameters extracted from the balance recovery task are based on those previously 
determined to be significantly different between mild PD and healthy controls, making them potential 
candidates to be used to quantify postural instability. Strategic, temporal, kinematic, and center of 
pressure parameters were determined.  
Strategic Parameters: Qualitative differences in the strategy used to recover from the balance 
disturbance were determined by analyzing video recorded during the trials. Parameters extracted from the 
video recordings include: the number of steps taken to regain balance, utilization of a single or multiple 
step response, and the foot used for the first step (right or left). A participant was defined as a multiple 
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step user if a multiple step response was used to regain balance in any of the three trials. A participant 
was classified as being step foot consistent if the same foot was used for the first step in all three trials. A 
trial was defined as a change-in-the-base-of-support if the foot lifted off the force plate and repositioned 
to change the base of support. The foot was required to translate 50mm or more in order to be considered 
a step.  
Temporal Parameters: A threshold method was used to determine four temporal events 
(disturbance onset, EMG onset, and step foot liftoff and landing times) which were used to define the 
temporal parameters reaction time, weight shift time and step duration. The following parameters and 
definitions were used. 1) Disturbance onset: time when the cable pull force exceeded the threshold. The 
cable threshold was defined as the mean plus 10 standard deviations of the force signal over the initial 
500 ms of data collection. 2) Muscle onset: the first time 25 consecutive EMG data points exceed the 
threshold. The EMG threshold value was defined as the mean plus five standard deviations of the signal 
over a 50 ms window prior to the disturbance. 3) Reaction time: time between disturbance onset and first 
TA muscle onset. 4) Liftoff time: time between disturbance onset and unloading of the vertical force 
component under the foot used for stepping, when the vertical force is less than 4% body weight. 5) 
Weight shift time: time between reaction time and liftoff time. 6) Landing time: time between disturbance 
onset and re-loading of the vertical force component under the foot used for stepping, when the vertical 
force is greater than 4% body weight. 7) Step duration: time between landing time and liftoff time.  
Ankle Kinematics: The ankle angle was determined using the measured motion data with the 
kinematics portion of a 3D inverse dynamics model (Vaughan, Davis, & O’Connor, 1992). The peak 
ankle plantarflexion/dorsiflexion angle during the initial stage of the response (prior to liftoff) and the 
angle at liftoff of the first step was extracted and expressed relative to the initial configuration.  
Center of Pressure (COP) Displacement: The anterior-posterior (AP) and medial-lateral (ML) 
COP locations were calculated as a function of time using the foot/floor reaction forces and moments. 
The whole-body COP location was analyzed from disturbance onset time to landing of the first step. The 
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AP and ML displacements of the COP were determined at liftoff and landing of the first step relative to 
the COP location at disturbance onset.  
Statistical Analysis: Statistical analysis was performed in SPSS 20.0 (SPSS Inc., Chicago, IL). 
All three trials for each participant were used to evaluate group differences in strategy parameters. A p-
value  0.05 defined significance. A Fisher’s two-tailed exact test was used to determine group 
differences in multiple vs. single step responses and consistency in choice of stepping limb. The 
Wilcoxon Rank Sum test was used to evaluate group differences in the number of steps in the response.   
Multiple step trials were averaged for each subject. Shapiro-Wilk’s tests were used to verify the 
assumption of normal distribution on all parameters. If the assumption was violated, the Mann-Whitney 
test for independent samples was used to determine group differences. If the assumption was confirmed, 
independent samples t-tests were used to determine group differences between the remaining outcome 
parameters for each specific aim.  
Results 
Ten people with PD and ten HC completed the study. All trials were included in the strategy 
analysis, but only multiple step strategy trials were included in the remaining analyses (temporal, 
kinematics, kinetics, COP), which left 9 participants in the PD group and 7 in the HC group. 
Anthropometric (weight and height), initial stance (stance width, initial COP location, initial force 
distribution) and pull characteristics (peak, duration, impulse) revealed no group differences and were not 
considered further (Table 3.2). 
The backwards pull consistently resulted in a stepping response which included the use of 
between one and five steps without falling or external assistance required to regain balance.  
Strategy: PD, compared to HC, utilized significantly more steps to recover from the balance 
disturbance (HC: 1.66 ± 0.63, PD: 2.43 ± 0.79, p = .035). Both PD participants and HC were more likely 
to use a multiple step response than a single step response (90% of PD, 70% of HC participants used a 
multiple step response, p = .496). PD participants were less consistent in the foot utilized for the first step 
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(30% of PD, 80% of HC participants were consistent, p = .06) but not quite to a significant level (Table 
3.3). 
One important observation was that in 9 trials across 6 different PD participants, compared to 
zero trials in HC, prior to stepping the step foot lifted off and moved slightly (Figure 3.1). This movement 
was not counted as the first step in the response as the change in base of support was considered 
negligible (foot translation less than 50mm). This movement was defined as a “base-width neutral step.” 
The use and characteristics of this movement will be considered as future work.  
Temporal: The only temporal variable that showed a significant group difference was weight shift 
time (HC: 242 ± 125 ms; PD: 407 ± 157 ms; p = .039) (Figure 3.2 and Table 3.4). Reaction time and step 
duration time were similar between groups.  
Kinematics: There were no significant differences in any of the kinematic parameters considered 
(Table 3.5). 
Center of Pressure: In PD, compared to HC, the COP was further back at both liftoff and landing, 
although not to a significant level (at liftoff, HC: 44 (36) mm, PD: 85 (44) mm posterior, p = .06; at 
landing, HC: 55 (33) mm, PD: 102 (65) mm, p = .09) (Table 6). There was no difference in COP position 
in the ML direction at either liftoff or landing.  
Discussion 
The purpose of this study was to investigate whether biomechanical differences previously 
observed in the response to a balance disturbance in mild PD continue to persist in moderate PD. In 
particular, we were interested in strategy, weight shift time, ankle angle, and center of pressure position. 
The results of this study suggest that some of the differences persist in moderate PD, but some aspects of 
the response change.  
Strategy: Moderate PD significantly affected the strategy used to respond to the balance 
disturbance- the PD group used more steps and tended to be less consistent in the choice of stepping foot. 
This is consistent with previous studies done in moderate-severe PD, but not consistent with our previous 
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study on mild PD. In addition, the use of the base-width neutral step was something that has not been 
reported before and was not seen in mild PD. The use of the base-width neutral step is very interesting, 
and perhaps an evolution of what we saw in mild PD. In the mild PD study, PD patients tended to shift 
their weight from side to side before finally lifting off , and therefore had longer weight shift times, 
different ankle kinematics as they fell backwards, and a further posterior COP position at landing. In 
moderate PD, it seems like now instead of shifting back and forth, some patients are actually lifting off, 
taking a tiny little step, before continuing their response which may be between 1-4 more steps. The 
inefficiency involved in taking a step that does not change the base of support as the center of mass is 
pulled backwards could significantly impair balance recovery.  
Temporal: Moderate PD did not affect the reaction time or the duration of the first step. Previous 
studies have shown that PD does not affect the reaction time after an external perturbation (Chong, Jones, 
& Horak, 1999; Horak, Frank, & Nutt, 1996b; Horak, Nutt, & Nashner, 1992). In the present study, PD 
did increase the weight shift time, which is the time between muscle activity onset and step foot liftoff. 
This is consistent with what was observed in the study on mild PD, where it was suggested that the 
inconsistent choice of the foot used for the initial step together with the longer weight shift time in the 
PD, compared to the HC, may be demonstrating what Jacobs et al. reported when healthy subjects were 
unable to pre-select their stepping foot: they had several anticipatory postural adjustments, leading to 
longer liftoff times compared to the condition where they were allowed to choose their stepping foot 
(Jacobs & Horak, 2007). In this situation, it is likely the use of the base-width neutral step that is 
significantly contributing to longer weight shift times. In addition, it is a promising result that weight shift 
time is longer in both mild PD (previous study), who do not have clinically diagnosed postural instability, 
and moderate PD, who do have clinically diagnosed postural instability. This is an encouraging result, 
and perhaps an increase in weight shift time is an early indicator of postural instability in PD.  
Kinematics and COP: Moderate PD did not affect the kinematics of the response. Notably, there 
was no difference in step length or height or in the ankle angle prior to liftoff. It is likely that the change 
in strategy to the use of the base-width-neutral step significantly changes the results seen in the ankle 
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angle; therefore we did not observe similar results to the study on mild PD. Moderate PD did not 
significantly affect the location of the COP at liftoff or landing; however PD tended to be further back at 
both liftoff and landing, which is consistent with the study on mild PD.   
Clinical Implications: The results of this study are promising in the search for an early indicator 
of postural instability in Parkinson’s disease. These results confirm that weight shift time, which is longer 
in mild PD (without clinical signs of postural instability), continues to be longer in moderate PD (with 
clinical signs of postural instability), making it a potential early marker of postural instability. 
Limitations: Limitations of this study include the small sample size and the fact that we did not 
have the same number of trials for every subject (only multiple step trials included in the majority of the 
analysis). Another limitation of this study is that subjects were only tested on medication. We do not have 
data to describe the effects of medication on this response. However, the long-term goal of this research is 
to determine biomechanical tests that can be adapted for clinical use, in which case the patients would be 
tested on their normal medication.  
Conclusions 
The first step in the response to a balance disturbance is impaired in moderate PD compared to 
healthy controls. Patients with moderate PD had to take more steps to regain balance, had a longer weight 
shift time, and the use of a base-width neutral step emerged as a strategy used to regain balance. Further 
work must examine if this is a further progression of postural instability compared to what has been 
observed in mild PD.  
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Sub Age Sex UPDRS UPDRS UPDRS H&Y Duration Medications Dose/Day
Num Motor #33 (yrs) (mg/day)
4002 71 F 47 28 2 3 13 Carbiodopa/Levodopa 600
Carbiodopa/Levodopa ER 200
Pramiprexole 1.5
4004 61 M 36 17 2 3 11 Carbidopa/Levodopa 1200
Entacapone 1200
Rasagiline 1
Ropinirole PR 12
4005 69 M 57 36 2 3 3 Carbidopa/Levodopa 750
Carbidopa/Levodopa ER 100
Ropinirole 9
4006 71 M 47 27 2 3 7 Carbidopa/Levodopa 800
Entacapone 800
Rasagiline 1
Pramipexole 3
Amantadine 100
4007 66 M 35 23 2 3 2 Carbidopa/Levodopa 600
Pramipexole 6
4008 63 M 65 41 2 3 9 Carbidopa/Levodopa 450
Carbidopa/Levodopa ER 200
Ropinirole 6
Amantadine 200
4010 64 M 44 31 2 3 9 Carbidopa/Levodopa 400
Carbidopa/Levodopa ER 800
Ropinirole 6
4011 68 M 53 30 2 3 11 Carbidopa/Levodopa 1000
Ropinirole 9
Amantadine 200
Benztropine 1
4012 72 F 50 33 2 3 8 Carbidopa/Levodopa 800
Carbidopa/Levodopa ER 700
Pramipexole 1.5
4013 72 M 62 41 2 3 5 Carbidopa/Levodopa 400
Amantadine 100/week
Average 67.7 49.6 30.7 2 3 7.8
Std Dev 4.00 10.00 7.56 0.00 0.00 3.58
Table 3.1. Characteristics of PD Participants 
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Table 3.2. Characteristics of Participant Groups; Pull and Initial Stance Characteristics 
  
HC (N = 10) PD (N = 10) p-value
Age (yrs)  68 (5) 68 (4) 0.677
Mass (kg) 75 (13) 85 (19) 0.192
Height (cm) 175 (6) 173 (10) 0.507
Pull Characteristics
Peak (N) 299 (57) 290 (59) 0.737
Duration (ms) 304 (15) 308 (34) 0.682
Impulse/wh (N-s/kg-m) .251 (.04) .232 (.06) 0.456
Initial Stance Characteristics
Stance Width (mm) 231 (38) 248 (63) 0.455
COP AP at Pull (mm) -.312 (1.9) 2.27 (5.37) 0.179
COP ML at Pull (mm) .015 (1.37) .823 (2.76) 0.418
Left Vertical Force at Pull (N) 394 (81) 450 (113) 0.216
Right Vertical Force at Pull (N) 393 (61) 431 (97) 0.241
Participant characteristics, pull characteristics, and initial stance characteristics showed no 
significant differences. Values are mean (standard deviation). P-values are based on t-tests. 
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Table 3.3. Strategy Results 
 
 
 
  
 
HC (N=10) PD (N=10) p-value 
No. Steps 1.66 (.63) 2.43 (.79) .035* 
% Consistent 80% 30.0% .064 
% Multiple Step 70% 90% .496 
 
No. Steps= total number of steps in response, % Consistent= percentage of 
participants who stepped with the same foot in the first step of all three trials, % 
Multiple Step= percentage of participants who used more than 1 step to recover 
balance in at least one trial. * Indicates p < .05 by Wilcoxon Rank Sum Test.  
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Table 3.4. Temporal Results in Multiple Step Trials 
.  
 
 
 
  
 
HC (N= 7) PD (N= 9) p-value 
Reaction Time (RT) (ms) 138 (34) 128 (15) .681
1
 
Weight Shift Time (WST) (ms) 242 (125) 407 (157) .039* 
Step Duration (STD) (ms) 149 (60) 134 (33) .580 
 
Significant differences observed between groups in weight shift time but not in 
reaction time or step duration. PD participants had longer weight shift times 
compared to healthy controls. 
1
Indicates use of Mann-Whitney test instead of t-
test. *Indicates p < .05 by t-test.  
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Table 3.5. Kinematic Results in Multiple Step Trials  
 
 
 
 
 
 
 
 
 
 
  
 HC (N = 7) PD (N = 9) p-value 
STL (mm) 183 (123) 148 (65) 0.681¹ 
STH (mm) 49.3 (34.8) 40.4 (24.9) 0.999¹ 
Liftoff Angle (deg) -.862 (2.58) .476 (2.27) 0.576 
Max Angle (deg) 2.37 (1.58) 3.55 (1.86) 0.511 
Min Angle (deg) -1.68 (1.86) -.993 (1.11) 0.606¹ 
Excursion (deg) 4.04 (2.24) 4.54 (1.79) 0.627 
 
No significant differences observed in kinematic parameters. STL= step length, STH= 
step height, Liftoff Angle= ankle plantarflexion/dorsiflexion angle at liftoff (+ 
indicates plantarflexion, - indicates dorsiflexion). Max/Min Angle= max PF (max) and 
DF (min) prior to liftoff, Excursion= max-min ankle angle. P-values based on t-tests or 
Mann-Whitney tests. 
1
Indicates use of Mann-Whitney test.  
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Table 3.6. Center of Pressure Parameters  
  
 HC (N = 7) PD (N = 9) p-value 
AP COP at Liftoff (mm) -43.8 (36.3) -85.3 (43.9) 0.063 
ML COP at Liftoff (mm) 113 (16) 116 (43) 0.828 
AP COP at Landing (mm) -55.4 (33.1) -102 (65.1) 0.088 
ML COP at Landing (mm) 89.8 (25.6) 105 (42.2) 0.411 
 
No significant differences observed between groups in center of pressure parameters. AP= 
anterior-posterior, ML= medial-lateral, COP= center of pressure. Liftoff and landing refer to 
the first step in a multiple step response. P- values based on t-tests.  
 
 
54 
  
Load Cell
EMG
Force Plate
Figure 3.1. Illustration of Temporal Parameters 
Plot illustrates the calculation of temporal parameters. RT= Reaction Time, WST= Weight Shift 
Time. Solid black line is load cell trace, solid blue line is EMG from stepping foot TA muscle. Solid 
red line is vertical force under the step foot. RT taken as time between muscle onset and disturbance 
onset, WST taken as time between force plate liftoff and muscle onset.  
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Figure 3.2. Frequency plot of Step Length Range for Multiple Step Trials 
Frequency plot for step length: number of trials in each range of step length for the first step in 
multiple step responses only. Only participants in the PD group used a step smaller than 50 
mm as the first step in a multiple step response.   
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Figure 3.3. Temporal Results in Multiple Step Trials 
Results for temporal parameters. RT= reaction time, WST= weight shift time, SDT= step 
duration time. Solid bars are HC group, striped bars are moderate PD group.  * indicates p < 
.05 by t-test. PD participants had significantly longer WST compared to HC.  
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Figure 3.4. Group Average Ankle Angle 
Group Average Ankle Angle: Solid Blue Line= mean ankle angle for HC group. Dashed red 
line= mean ankle angle for PD group. Mean lines for first step in multiple step responses only.  
Dashed blue lines= +/- 1 standard deviation of the HC mean, dash-dotted red lines= +/- 1 
standard deviation of the PD mean. No significant difference in ankle angle prior to liftoff.  
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Figure 3.5. Representative Center of Pressure Plot 
Representative plots of COP from disturbance onset to landing of the first step in a HC (solid 
blue line) and PD (dashed red line) participant. X marks disturbance onset, * marks liftoff, 
and + marks landing. Plot illustrates significantly different COP movement in PD compared 
to HC during first step in the response.  
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CHAPTER FOUR:  THE EFFECT OF MODERATE PARKINSON’S DISEASE ON THE 
PREPARATION FOR COMPENSATORY BACKWARD STEPPING 
Introduction 
Postural instability leading to falls is one of the most disabling symptoms of Parkinson’s disease 
(PD). The 3 month fall rate is estimated at 46% for the general population with PD, and 21% among those 
who have no history of falls (Pickering et al., 2007). Falls have devastating effects on quality of life 
including fractures, hospitalization, loss of independence, and restriction of activities (Bloem, van Vugt, 
& Beckley, 2001; Gray & Hildebrand, 2000; Lachman et al., 1998; Pickering et al., 2007; Tinetti, de 
Leon, Doucette, Baker, & Dorothy, 1994). Interventions to reduce fall risk are most effective if they are 
implemented before someone falls, but the current clinical assessments for postural instability in PD are 
not sensitive enough to track the development of postural instability prior to a fall (Munhoz et al., 2004; 
Visser et al., 2003). While progress has been made in identifying clinical and physiological parameters 
that can more accurately predict fall risk (Duncan et al., 2012; Kerr et al., 2010; King, Priest, Salarian, 
Pierce, & Horak, 2012; Latt, Lord, Morris, & Fung, 2009), there is still a need to understand how postural 
instability progresses so that appropriate interventions can be introduced at appropriate times. Laboratory-
based experiments may provide the missing link in fall-risk factor development.  
The response to a large balance perturbation often involves a step response to reconfigure the 
base of support, which must be done quickly and appropriately in order to prevent a fall. PD impairs the 
step response and subjects typically use shorter than normal steps, multiple anticipatory postural 
adjustments, have a longer liftoff time, and are less consistent in the choice of stepping limb (Jacobs & 
Horak, 2006; Jacobs, Horak, & Nutt, 2005). It is thought that this altered response may result from an 
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inability to quickly select an appropriate response, as similar effects occur when young adults are unable 
to pre-select their stepping foot (Jacobs & Horak, 2007).  
In order to preserve stability when taking a step, a person must shift their weight to the stance 
foot prior to lifting off with the swing foot for the step. It is well-established that during voluntary tasks 
such as gait initiation, an anticipatory postural adjustment (APA) is used in order to help propel the center 
of mass (COM) towards the stance foot. An APA is characterized as a vertical loading and then unloading 
of the swing foot, resulting in a medial-lateral shift in the COP towards the swing leg (McIlroy & Maki, 
1993). During external perturbations, these APAs are not as characteristically seen, and even when they 
are present they are not effective in propelling the COM towards the stance foot (McIlroy & Maki, 1993, 
1999).  
Investigation of the control of the center of pressure during the response to a balance disturbance 
has shown significant differences between those with PD compared to healthy controls, particularly in the 
step initiation phase. In our previous study (McVey, et al., 2009), most differences between mild PD and 
healthy controls occurred prior to liftoff of the first step, which implies that after liftoff the characteristics 
of the step were similar between the two groups. Further investigation of this phase of the response and 
the center of pressure showed that some of the PD patients were using multiple anticipatory postural 
adjustments (APAs) prior to liftoff (McVey, et al., 2008). Another recent study has shown that patients 
with Parkinson’s disease use APAs more frequently than healthy controls (King, St George, Carlson-
Kuhta, Nutt, & Horak, 2010), and that the use of an APA results in later liftoff times, and the use of 
significantly more and shorter steps to regain balance. In addition, the PD participants sometimes used 
multiple APAs, a less efficient response, compared to healthy controls who never used more than one 
APA. However, this study included a large range of severity levels within the PD group, so the 
relationship between postural instability and PD severity level remains unclear.  
In order to better understand the use of multiple APAs in PD patients, Jacobs investigated the use 
of APAs in healthy young subjects in response to external predictable and unpredictable perturbations 
(Jacobs & Horak, 2007). They defined an APA as a lateral weight shift preceding a step and measured it 
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from the lateral displacements of the COP that occurred between onset of the disturbance to toe off of the 
stepping foot. In the unpredictable condition, young subjects sometimes used multiple APAs 
(approximately 30% of the trials showed multiple APAs compared to 70% with only one APA). In 
addition, APA onset latencies and durations were longer in the unpredictable condition compared to the 
predictable condition. Finally, the onset latencies and durations were longest in the cases when subjects 
used multiple APAs.  
Previous studies of postural instability in PD have primarily focused on patients who already 
exhibit balance deficits (Chong, Horak, & Woollacott, 2000; Dimitrova, Nutt, & Horak, 2004; Horak, 
Dimitrova, & Nutt, 2005; Horak, Frank, & Nutt, 1996; Jacobs & Horak, 2006). For instance, Jacobs et al. 
demonstrated that moderate and severe PD participants, compared to healthy controls, utilized shorter 
steps (Jacobs & Horak, 2006), multiple anticipatory postural adjustments, and were less consistent in the 
choice of stepping limb in response to a backwards surface translation (Jacobs et al., 2005). A preliminary 
study by our group has demonstrated impairments in balance recovery in patients with early Parkinson’s 
disease and no clinical signs of postural instability (H&Y = 2). This study demonstrated that those with 
PD but without postural instability, compared to age-range-matched controls, used a longer weight shift 
time (time between muscle onset and liftoff of the stepping foot), altered ankle rotation prior to liftoff, 
and had a more posterior displacement of the COP at landing of the first step in the response. The most 
interesting result of the preliminary study was that most of the differences between the two groups were 
found in the first stage of the response- prior to liftoff of the first step. In addition, the COP patterns 
observed during this stage were quite different between the two groups.  
Therefore, the goal of this study was to further investigate the COP movement during the 
preparation stage of the step response in PD patients with clinically diagnosed postural instability (H&Y 
3), compared to healthy controls. Further studies are required to determine if these variables are sensitive 
and specific to postural instability.  
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Methods 
Participants: Ten participants diagnosed with moderate PD (PD: Age 68 ± 4 years, range 61-73 
years, Height: 173 ± 10 cm, range 157-186 cm, Mass: 85 ± 19 kg, range 56-116 kg) and ten healthy age-
range matched controls (HC: Age 68 ± 5 years, range 63-79 years, Height: 175 ± 6 cm, range 170-186 
cm, Mass: 75 ± 13 kg, range 55-92 kg) completed the study (8 male and 2 female in each group). 
Exclusion criteria included dementia (MMSE score less than 24) (Folstein, Folstein, & McHugh, 1975), 
significant depression (Beck Depression Inventory > 14) (Beck, Ward, Mendelson, Mock, & Erbaugh, 
1961) and inability to ambulate without assistance. All participants gave written informed consent 
approved by the University of Kansas Medical Center (KUMC) Human Subject’s Committee. 
People diagnosed with idiopathic PD were recruited from the KUMC Parkinson’s Disease and 
Movement Disorder Center and were assessed with the Unified Parkinson’s Disease Rating Scale 
(UPDRS). Exclusion criteria included patients who had a H&Y score other than 3 (only participants with 
H&Y 3 were included in this study), those who had undergone deep brain stimulation or had a history of 
significant musculoskeletal, neurological, or cognitive impairments other than those associated with PD. 
Participants with PD were instructed to maintain their normal medication schedule (Table 4.1) and were 
tested on the medication “ON” phase which was 2.22 ± 1.1 hours since last dose. Healthy controls (HC) 
living independently were recruited from the community. Medical history and a physical examination 
excluded those with cardiovascular, musculoskeletal and neurological impairments. Characteristics of PD 
participants are shown in Table 4.1.  
Task. The participant stood with arms crossed at the chest and weight equally distributed between 
the feet. The participant also wore standardized footwear. For safety purposes, a safety harness connected 
to an overhead support was worn by the participant and a research assistant stood nearby to help prevent 
injury in case of a fall. The participant wore an adjustable but rigid waist harness that was connected to a 
weight-drop mechanism via a cable in the back of the harness. When triggered, the weight-drop 
mechanism produced a posterior waist pull by dropping a weight (20% body weight) with a pull distance 
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equal to 8.7% of waist height (Luchies, Alexander, Schultz, & Ashton-Miller, 1994). The selected pull 
magnitude was large enough to ensure that each participant used a step response to recover balance. The 
participant was instructed to respond naturally to the posterior pull, which was repeated until three good 
trials were obtained. Examples of bad trials included not stepping onto a force plate or obstructing the 
cameras' view of kinematic markers. A maximum of six trials were performed by each participant.  
Experimental Measurements: Video, motion, force plate, electromyography (EMG), and load cell 
data were collected for each trial. Motion data was sampled at 100 Hz using an Optotrak (Northern 
Digital, Inc., Waterloo, Canada) dual bar motion analysis system. Markers were placed bilaterally on the 
2
nd
 toe, ankle, heel, calf, and knee. EMG data was measured using an eight channel Delsys surface 
electrode system (Delsys, Boston, MA, USA). Electrodes were placed bilaterally on the tibialis anterior 
(TA). Foot/floor reaction forces and moments were measured using three AMTI (Advanced Mechanical 
Technology Inc.; Watertown, MA, USA) six-component force plates. A biaxial custom-built load cell was 
used to measure the tensile force in the cable attached to the waist harness. Analog data was sampled at 
1000 Hz using a 16-bit A/D data acquisition system. 
Analysis: Force plate and load cell data were filtered using a second order low pass Butterworth 
filter with a cutoff frequency of 20 Hz. Initial and final-time artifacts were minimized using forward and 
backward reflection of the data (Smith, 1989), and phase shift was eliminated by using forward and 
backward passes(Winter, 1990). Data from all trials were processed using MATLAB (Mathworks, Natick, 
MA, USA). Trials were classified as single or multiple step trials. Only the first step in a multiple step 
response was compared. A step was defined if the foot lifted off the force plate and repositioned to 
change the base of support. The foot was required to translate 50 mm or more in order to be considered a 
step. One important observation was that in 9 trials across 6 different PD participants, compared to zero 
trials in HC, prior to stepping the step foot was unloaded and slightly translated. This movement was not 
counted as the first step in the response as the change in base of support was considered negligible (foot 
translation less than 50 mm). This movement was defined as a “base-width neutral step.” The use and 
characteristics of this movement will be considered as future work.  
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The whole body center of pressure (COP) was calculated for the time period of disturbance onset 
to liftoff of the first step, and divided into two stages. Stage one was defined as disturbance onset to 
weight shift onset. Stage two was defined as weight shift onset to step foot liftoff. Weight shift onset was 
defined as the last change in the location of the COP in the ML direction prior to liftoff. The anterior-
posterior (AP) and medial-lateral (ML) displacement, path length, average velocity, and time duration of 
each stage were calculated.  
Center of Pressure Parameters: The anterior-posterior (AP) and medial-lateral (ML) 
displacement, path length, average velocity, and the duration of each stage were calculated. Displacement 
was calculated as the difference between starting and ending positions of the COP in each stage. Path 
length was defined as the total distance traveled by the COP in each stage. Average velocity over the 
stage was calculated as distance/time in each stage.  
Anticipatory Postural Adjustments: Anticipatory postural adjustments were defined similarly to 
the methods in Jacobs and McIlroy. APAs were determined by looking at the lateral COP signal from 500 
ms prior to onset of the disturbance to liftoff of the first step. The baseline signal was defined by the 
average of the signal for 500 ms prior to onset of the disturbance. If the COP traveled more than 1cm 
from the baseline an APA was noted to begin. Trials were classified as having 0, 1, or 2 or more APAs. 
Figures 4.1 and 4.2 illustrate the different preparation strategies.  
Statistical Analysis: Statistical analysis was done with SPSS 20.0 (SPSS Inc., Chicago, IL). A p-
value  0.05 was used for significance. The Fisher’s Exact Test was used to evaluate group differences in 
the number of trials where multiple APAs were used and consistency of preparation strategy. Shapiro-
Wilks tests were used to test COP parameters for normal distribution. Those that were normally 
distributed were analyzed using the Student’s T-Test, those that were not normally distributed were 
analyzed using the Mann-Whitney U Test.  
In order to further examine the effect of the use of multiple APAs on the response, follow up tests 
were done to compare stepping strategy (0 or 1 APAs compared to 2 or more APAs) to the COP 
parameters. Linear mixed modeling, with subject as a random factor, and a variance components 
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covariance structure were used. Differences were analyzed among three groups: healthy controls (who all 
used either 0 or 1 APAs), PD who used 0 or 1 APAs, and PD who used 2 or more APAs.  
Results 
Ten people with PD and ten HC completed the study. All trials were included in the strategy 
analysis, but only multiple step strategy trials were included in the remaining analyses (temporal, 
kinematics, kinetics, COP), which left 9 participants in the PD group and 7 in the HC group. 
Anthropometric (weight and height), initial stance (stance width, initial COP location, initial force 
distribution) and pull characteristics (peak, duration, impulse) revealed no group differences and were not 
considered further (Table 4.2). 
The backwards pull consistently resulted in a stepping response which included the use of 
between one and five steps without falling or external assistance required to regain balance.  
Strategy: PD, compared to HC, utilized significantly more steps to recover from the balance 
disturbance (HC: 1.66 ± 0.63, PD: 2.43 ± 0.79, p = .035). Both PD participants and HC were more likely 
to use a multiple step response (90% PD, 70% HC participants, p = .496).  
APAs: Figure 4.3 shows the proportion of trials for each preparation strategy. PD participants 
used multiple APAs in 37% (11/30) of all trials, compared to HC who never used multiple APAs 
(p=.0003). Approximately 55% (6/11) of the trials where multiple APAs were used involved the use of a 
base-width neutral step. The preparation strategy (use of 0, 1, or 2 or more APAs) was more variable in 
PD participants, with only 30% (3/10) using a consistent strategy compared to 80% (8/10) of HC 
participants (not significant in Fisher’s Exact Test: p=.07).   
 In multiple step trials, PD participants used multiple APAs in 41% of multiple step trials, where 
HC never used more than one APA (p=.005). Figure 4.4 shows the proportion of trials in each group 
using 0, 1, or 2 or more APAs. Approximately half (5/9, 56%) of the trials where multiple APAs were 
used were trials that involved the use of a base-width neutral step. The preparation strategy (use of 0, 1, or 
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2 or more APAs) was more variable in PD participants, with only 30% (3/10) using a consistent strategy 
compared to 80% (8/10) of HC participants.  
Center of Pressure Parameters: There were significant differences in several COP parameters, all 
in the first stage of the response, that is prior to the final weight shift began for the first step. In stage 1, 
PD compared to HC, demonstrated a longer AP COP Path Length (PD: 85.2 ± 48.6 mm, HC: 33.7 ± 22.4 
mm, p = .02), a longer ML COP Path Length (PD: 135.1 ± 85.1 mm, HC: 30.3 ± 29.5 mm, p = .008), a 
longer duration of stage 1 (PD: 384.3 ± 173.8 ms HC: 231.6 ± 65.6 ms, p = .034) , and a higher ML 
average velocity during stage 1 (PD: 286 ± 132 mm/s, HC: 108 ± 100 mm/s, p = .01) (Table 4.3 and 
Figure 4.5,4.6). There were no significant differences in any parameters in stage 2 of the response (Table 
4.4).   
Effects of Preparation Strategy on COP Characteristics: Follow up tests further examined 
variables where significant differences were found to determine the effect of preparation strategy on the 
COP parameters. Significant differences were found in the duration of stage 1, ML and AP path length, 
and ML average velocity in stage 1 between the PD group using multiple APAs and both the healthy 
controls and the PD group using 0 or 1 APAs (Table 4.5 and Figure 4.7).  
Clinical Scores not significantly related to Preparation Strategy: None of the clinical UPDRS 
measures investigated (total UPDRS score, UPDRS motor score, and UPDRS PIGD sub-section) were 
significantly different between PD participants who used multiple APAs compared to PD participants 
who never used multiple APAs. There was a trend towards higher scores across all measures, but not to a 
significant level (Figure 4.8). In addition, we saw no correlation between fall history and the use of 
multiple APAs. In fact, only two of the participants did not report a history of falls, and both of these 
participants used multiple APAs in at least one trial.  
Discussion 
The goal of this study was to investigate the COP during the preparation stage of the step 
response in PD patients with clinically diagnosed postural instability (H&Y 3), compared to healthy 
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controls. Participants with moderate PD used different preparation strategies prior to taking a step, and the 
movement of the center of pressure during the preparation stage reflected these differences.   
Participants with moderate PD used more than one APA prior to liftoff of the first step in a 
multiple step response in 37% of trials. The use of multiple APAs in the PD group is consistent with 
findings by King et al., who found that 14% of patients with mild-severe PD used multiple APAs, and 
healthy controls never used multiple APAs (King et al., 2010). The increased percentage of multiple APA 
trials in this study can possibly be explained by the use of the base-width neutral step. If we ignore trials 
in which a base-width neutral step occurs, the use of multiple APAs reduces to 13.3% (4/30), which is 
consistent with King et al. In addition, the current study compared healthy controls to only those with 
moderate PD (H&Y 3) where the King et al. study included a more diverse patient population with mild 
to severe PD (H&Y 1.5-4 on medication).  
McIlroy and Maki have shown that healthy subjects generally do not use an APA in response to 
an unpredictable disturbance, and that when they do use an APA, it is generally not effective in propelling 
the COM towards the stance foot (McIlroy & Maki, 1993). They concluded that the APA may represent a 
pre-planned response that is interrupted by the need to react quickly to the destabilization caused by the 
perturbation. It is unclear why the PD participants not only persist in using APAs, but often use more than 
1 APA. Horak et al. found that healthy young participants were likely to use more than 1 APA in 
response to an unexpected perturbation when they were not allowed to pre-select their stepping foot, 
again suggesting that multiple APAs suggest an interruption to a pre-planned response (Jacobs & Horak, 
2007).  
No significant correlations were found with respect to clinical scores and preparation strategy. 
This may be due in part to the homogeneous nature of the PD participants, as all were H&Y 3. The 
analysis of additional PD severity levels to this study may help to understand how clinical scores relate to 
preparation strategy. In addition, part of the motivation for this study is the lack of sensitivity of clinical 
measures, so it is not surprising that the clinical scores are not picking up on these changes within this 
group. The fact that we found no correlation with fall history is disappointing, as that would be a sure 
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indicator that these analyses may be useful in the development of a more sensitive fall-risk predictor, but 
this study was not designed to study fall risk, and further studies need to more carefully examine the 
potential correlation of fall risk to preparation strategy.  
Clinical Implications: The results of this study are promising in the search for an early indicator 
of postural instability in Parkinson’s disease. These results suggest that COP measures during the 
preparation phase of the response may be early indicators of postural instability. This is exciting because 
the preparation phase of the response cannot be visually observed, so the use of these measures may offer 
clinical insight that is not otherwise available. 
The center of pressure parameters further explain the differences we observed in the first study, 
which showed that moderate PD patients had longer weight shift time and altered COP patterns prior to 
liftoff of the response. The results from this study suggest that the main impairment in the response 
happens prior to the final weight shift, and the measures of path length, time to final weight shift, and ML 
average velocity may be important measures of postural instability.  
Limitations 
A limitation of this study is that subjects were only tested on medication. We do not have data to 
describe the effects of medication on this response. However, the long-term goal of this research is to 
determine biomechanical tests that can be adapted for clinical use, in which case the patients would be 
tested on their normal medication.  
Another limitation of this study is the small sample size, particularly when groups were further 
divided based on preparation strategy. It is noted that the linear mixed model analyses are exploratory, 
and care has been taken to be conservative in interpretation of all results.  
Conclusions 
The preparation phase of the response to an external perturbation is impaired in moderate PD. 
The use of multiple APAs results in later liftoff times and significantly different movement in the center 
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of pressure prior to liftoff. Furthermore, the differences in the response can be attributed to the stage of 
preparation prior to final weight shift. This portion of the response and these parameters should be further 
investigated for their value in a more sensitive measure of postural instability.  
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Sub Age Sex UPDRS UPDRS UPDRS H&Y Duration Medications Dose/Day
Num Motor #33 (yrs) (mg/day)
4002 71 F 47 28 2 3 13 Carbiodopa/Levodopa 600
Carbiodopa/Levodopa ER 200
Pramiprexole 1.5
4004 61 M 36 17 2 3 11 Carbidopa/Levodopa 1200
Entacapone 1200
Rasagiline 1
Ropinirole PR 12
4005 69 M 57 36 2 3 3 Carbidopa/Levodopa 750
Carbidopa/Levodopa ER 100
Ropinirole 9
4006 71 M 47 27 2 3 7 Carbidopa/Levodopa 800
Entacapone 800
Rasagiline 1
Pramipexole 3
Amantadine 100
4007 66 M 35 23 2 3 2 Carbidopa/Levodopa 600
Pramipexole 6
4008 63 M 65 41 2 3 9 Carbidopa/Levodopa 450
Carbidopa/Levodopa ER 200
Ropinirole 6
Amantadine 200
4010 64 M 44 31 2 3 9 Carbidopa/Levodopa 400
Carbidopa/Levodopa ER 800
Ropinirole 6
4011 68 M 53 30 2 3 11 Carbidopa/Levodopa 1000
Ropinirole 9
Amantadine 200
Benztropine 1
4012 72 F 50 33 2 3 8 Carbidopa/Levodopa 800
Carbidopa/Levodopa ER 700
Pramipexole 1.5
4013 72 M 62 41 2 3 5 Carbidopa/Levodopa 400
Amantadine 100/week
Average 67.7 49.6 30.7 2 3 7.8
Std Dev 4.00 10.00 7.56 0.00 0.00 3.58
Table 4.1. Characteristics of PD Participants 
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HC (N = 10) PD (N = 10) p-value
Age (yrs)  68 (5) 68 (4) 0.677
Mass (kg) 75 (13) 85 (19) 0.192
Height (cm) 175 (6) 173 (10) 0.507
Pull Characteristics
Peak (N) 299 (57) 290 (59) 0.737
Duration (ms) 304 (15) 308 (34) 0.682
Impulse/wh (N-s/kg-m) .251 (.04) .232 (.06) 0.456
Initial Stance Characteristics
Stance Width (mm) 231 (38) 248 (63) 0.455
COP AP at Pull (mm) -.312 (1.9) 2.27 (5.37) 0.179
COP ML at Pull (mm) .015 (1.37) .823 (2.76) 0.418
Left Vertical Force at Pull (N) 394 (81) 450 (113) 0.216
Right Vertical Force at Pull (N) 393 (61) 431 (97) 0.241
Table 4.2. Characteristics of Participant Groups; Initial Stance and Pull Characteristics 
Participant characteristics, pull characteristics, and initial stance characteristics showed no 
significant differences. Values are mean (standard deviation). P-values are based on t-tests. 
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Figure 4.1. Illustration of Preparation Strategies in Healthy Controls 
Illustration of Preparation Strategies in Healthy Controls. Top graph is a trial where no APA was used; 
bottom graph is a trial where one APA was used. Plots begin at disturbance onset and end at liftoff of 
the first step. Positive numbers are towards stance foot, negative numbers towards swing foot. Notice 
in the bottom graph (1 APA) the COP shifts to the swing foot first before shifting to stance foot.   
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Figure 4.2. Illustration of Preparation Strategies in PD Participants 
Illustration of Preparation Strategies in PD Participants. Top graph is a trial where no APA was used; middle 
graph is a trial where one APA was used, bottom graph is a trial where two APAs were used. Plots begin at 
disturbance onset and end at liftoff of the first step. Positive numbers are towards stance foot, negative numbers 
towards swing foot. Notice in the bottom graph (2 APAs) the COP shifts directions more than once prior to 
shifting towards stance foot.   
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Figure 4.3. Frequency of Preparation Strategy Across Groups 
Frequency of Preparation Strategy Across Groups. APA= Anticipatory Postural Adjustment, PD= Moderate 
Parkinson’s Disease Group, HC= Healthy Control Group. PD participants used multiple APAs in 37% of 
trials, compared to HC participants who never used multiple APAs.  
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Figure 4.4. Preparation Strategies in Multiple Step Trials 
Preparation Strategies in Multiple Step Trials. APA= Anticipatory Postural Adjustment, PD= Moderate 
Parkinson’s Disease Group, HC= Healthy Control Group. Healthy controls always used 0 or 1 APA, where 
PD participants occasionally used multiple APAs.   
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Multiple Steps- Stage 1 HC (N=7) PD (N=9) p-value
AP Displacement Stage 1 (mm) -26.2 (25.8) -66.0 (46.8) 0.063
ML Displacement Stage 1 (mm) 26.5 (29.3) 52.7 (71.8) 0.382
AP Path Length Stage 1 (mm) 33.7 (22.4) 85.2 (48.6) 0.022*
ML Path Length Stage 1 (mm) 30.3 (29.5) 135.1 (85.1) 0.008*
Time Stage 1 (ms) 231.6 (65.6) 384.3 (173.8) 0.034*
AP Ave. Vel. Stage 1 (mm/ms) .127 (.066) .181 (.087) 0.197
ML Ave. Vel. Stage 1 (mm/ms) .108 (.100) .286 (.132) 0.01*
Figure 4.5. Center of Pressure Parameters in Stage 1 of Response 
Center of Pressure Parameters in Stage 1 of the response (prior to final weight shift), in the first step 
of multiple step responses. AP= anterior-posterior, ML= medial-lateral, HC= healthy control, PD= 
moderate PD group. P-values based on t-tests, * indicates p < .05.  
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Multiple Steps- Stage 2 HC (N=7) PD (N=9) p-value
AP Position at Liftoff (mm) -43.8 (36.3) -85.3 (43.9 0.063
ML Position at Liftoff (mm) -112.6 (16.3) -116.1 (42.9) 0.828
AP Displacement Stage 2 (mm) -17.5 (21.7) -19.3 (28.2) 0.889
ML Displacement Stage 2 (mm) -138.4 (34.5) -168.2 (104.2) 0.482
AP Path Length Stage 2 (mm) 33.8 (12. 1) 36.7 (18.9) 0.735
ML Path Length Stage 2 (mm) 139.5 (35.0) 171.7 (104.8) 0.451
Time Stage 2 (ms) 149.1 (58.4) 151.5 (62.4) 0.939
AP Ave. Vel. Stage 2 (mm/ms) .266 (.125) .308 (.189) 0.625
ML Ave. Vel. Stage 2 (mm/ms) 1.066 (.536) 1.140 (.673) 0.816
Figure 4.6. Center of Pressure Parameters in Stage 2 of Response 
Center of Pressure Parameters in Stage 2 of the response (final weight shift to liftoff of first 
step) in the first step of multiple step responses. AP= anterior-posterior, ML= medial-lateral, 
HC= healthy control, PD= moderate PD group. P-values based on t-tests. 
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Figure 4.7. Center of Pressure Parameters in Stage 1 of Response 
Center of Pressure Parameters in Stage 1 of the response (prior to final weight shift), in the first step 
of multiple step responses. AP= anterior-posterior, ML= medial-lateral, HC= healthy control, PD= 
moderate PD group. P-values based on t-tests, * indicates p < .05.  
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Figure 4.8. Average Velocities During Preparation Phase of Response 
Average velocities during Stage 1 and Stage 2 of first step in response. Stage 1= Disturbance onset 
to final weight shift, Stage 2= final weight shift to liftoff of first step, * Indicates p < .05 by t-test.   
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Figure 4.9. COP Parameters by Preparation Strategy 
COP parameters by preparation strategy (controls (N=7) who all used either 0 or 1 APAs, PD who used 
either 0 or 1 APA (N=8), and PD who used 2 or more APAs (N=6)). + Indicates pairwise group 
difference from Linear Mixed Model after Bonferroni correction with p < .05.  
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HC PD 0 or 1 APA PD Multiple APAs Main P
(N = 7) (N = 8) (N = 6)
AP Path Length S1 (mm) 30.5 (13.3) 45.7 (14.6) 138 (18) 0.001
ML Path Length S1 (mm) 29.9 (22.3) 64.8 (23.0) 247 (28) 0.000
Duration S1 (ms) 227 (33) 280 (34) 570 (42) 0.000
ML Velocity S1 (mm/s) 108 (44) 184 (47) 410 (57 0.002
Table 4.3. COP Parameters by Preparation Strategy 
COP Parameters by Preparation Strategy. AP= anterior-posterior, ML= medial-lateral, S1= stage 1 
(onset of disturbance to final weight shift prior to liftoff). APA= anticipatory postural adjustment. 
Main P= p-value for effect of strategy based on Linear Mixed Model.  
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Figure 4.10. UPDRS Scores by Preparation Strategy 
UPDRS scores by preparation strategy. APA= anticipatory postural adjustment, UPDRS= 
Unified Parkinson’s Disease Rating Scale, PIGD= Postural instability and Gait Disorder 
subsection of UPDRS. 
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CHAPTER FIVE:  THE EFFECT OF STEP STRATEGY ON BALANCE RECOVERY IN 
MODERATE PARKINSON’S DISEASE 
Introduction 
Postural instability leading to falls is one of the most disabling symptoms of Parkinson’s disease 
(PD). The 3 month fall rate is estimated at 46% for the general population with PD, and 21% among those 
who have no history of falls (Pickering et al., 2007). Falls have devastating effects on quality of life 
including fractures, hospitalization, loss of independence, and restriction of activities (Bloem, van Vugt, 
& Beckley, 2001; Gray & Hildebrand, 2000; Lachman et al., 1998; Pickering et al., 2007; Tinetti, de 
Leon, Doucette, Baker, & Dorothy, 1994). Interventions to reduce fall risk are most effective if they are 
implemented before someone falls, but the current clinical assessments for postural instability in PD are 
not sensitive enough to track the development of postural instability prior to a fall (Munhoz et al., 2004; 
Visser et al., 2003). While progress has been made in identifying clinical and physiological parameters 
that can more accurately predict fall risk (Duncan et al., 2012; Kerr et al., 2010; King, Priest, Salarian, 
Pierce, & Horak, 2012; Latt, Lord, Morris, & Fung, 2009), there is still a need to understand how postural 
instability progresses so that appropriate interventions can be introduced at appropriate times. Laboratory-
based experiments may provide the missing link in fall-risk factor development.  
The response to a large balance perturbation often involves a step response to reconfigure the 
base of support, which must be done quickly and appropriately in order to prevent a fall. It is well 
documented that this response deteriorates with age, and even further with Parkinson’s disease. Older 
adults use smaller, multiple steps to respond to a balance disturbance where young adults use a single 
larger step (Luchies, Alexander, Schultz, & Ashtonmiller, 1994; Maki & McIlroy, 2005; McIlroy & 
Maki, 1996). PD further impairs the step response and subjects typically use shorter than normal steps, 
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multiple anticipatory postural adjustments, have a longer step foot liftoff time, and are less consistent in 
the choice of stepping limb compared to healthy age-matched controls (Jacobs & Horak, 2006; Jacobs, 
Horak, & Nutt, 2005).  
Studies in Parkinson’s disease have demonstrated that participants with moderate to severe PD, 
compared to healthy controls, utilize shorter steps and multiple anticipatory postural adjustments (APAs) 
in response to a backwards surface translations (Jacobs & Horak, 2006; King, St George, Carlson-Kuhta, 
Nutt, & Horak, 2010). However most studies in PD have primarily focused on patients who have already 
been clinically diagnosed with postural instability, already exhibit major balance deficits, and have a wide 
range of severity levels (H&Y II-V) (Chong, Horak, & Woollacott, 2000; Dimitrova, Nutt, & Horak, 
2004; Horak, Dimitrova, & Nutt, 2005; Horak, Frank, & Nutt, 1996; Jacobs & Horak, 2006; King et al., 
2010). It is not clear how postural instability progresses and how it relates to disease severity. In an 
attempt to elucidate potential biomechanical measurements that may be candidates for early markers of 
postural instability, our group recently investigated the effects of mild PD on the biomechanics of the step 
response and determined that even mild PD impairs the step response (McVey, et al., 2009). Subsequent 
work showed that the first step in the response to a balance disturbance is also impaired in moderate PD 
compared to healthy controls. Patients with moderate PD had to take more steps to regain balance, had a 
longer weight shift time, and the use of a base-width neutral step emerged as a strategy used to regain 
balance. The purpose of this study was to examine the effect of response strategy on balance recovery and 
to characterize the base-width neutral step (BNS).  
Methods 
Participants: Ten participants diagnosed with moderate PD (PD: Age 68 ± 4 years, range 61-73 
years, Height: 173 ± 10 cm, range 157-186 cm, Mass: 85 ± 19 kg, range 56-116 kg) and ten healthy age-
range matched controls (HC: Age 68 ± 5 years, range 63-79 years, Height: 175 ± 6 cm, range 170-186 
cm, Mass: 75 ± 13 kg, range 55-92 kg) completed the study (8 male and 2 female in each group). 
Exclusion criteria included dementia (MMSE score less than 24) (Folstein, Folstein, & McHugh, 1975), 
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significant depression (Beck Depression Inventory > 14) (Beck, Ward, Mendelson, Mock, & Erbaugh, 
1961) and inability to ambulate without assistance. All participants gave written informed consent 
approved by the University of Kansas Medical Center (KUMC) Human Subject’s Committee. 
People diagnosed with idiopathic PD were recruited from the KUMC Parkinson’s Disease and 
Movement Disorder Center and were assessed with the Unified Parkinson’s Disease Rating Scale 
(UPDRS). Exclusion criteria included patients who had a H&Y other than 3 (only H&Y 3 included in this 
study), those who had undergone deep brain stimulation or have had a history of significant 
musculoskeletal, neurological, or cognitive impairments other than those associated with PD. Participants 
with PD were instructed to maintain their normal medication schedule (Table 5.1) and were tested on the 
medication “ON” phase which was 2.22 ± 1.1 hours since last dose. Healthy controls (HC) living 
independently were recruited from the community and age-range matched to the PD group. Medical 
history and a physical examination excluded those with cardiovascular, musculoskeletal and neurological 
impairments. 
Task: The participant stood with arms crossed at the chest and weight equally distributed between 
the feet. The participant also wore standardized footwear. For safety purposes, a safety harness connected 
to overhead support was worn by the participant and a research assistant stood nearby to help prevent 
injury in case of a fall. The participant wore an adjustable but rigid waist harness that was connected to a 
weight-drop mechanism via a cable in the back of the harness. When triggered, the weight-drop 
mechanism produced a posterior waist pull by dropping a weight (20% body weight) with a pull distance 
equal to 8.7% of waist height (Luchies, Alexander, Schultz, & Ashton-Miller, 1994). The selected pull 
magnitude was large enough to ensure that each participant used a step response to recover balance. The 
participant was instructed to respond naturally to the posterior pull, which was repeated until three good 
trials were obtained. Examples of bad trials included not stepping onto a force plate or obstructing the 
cameras' view of kinematic markers. A maximum of six trials were performed by each participant.  
Experimental Measurements: Video, motion, force plate, electromyography (EMG), and load cell 
data were collected for each trial. Motion data was be sampled at 100 Hz using an Optotrak (Northern 
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Digital, Inc., Waterloo, Canada) dual bar motion analysis system. Markers were placed bilaterally on the 
2
nd
 toe, ankle, heel, calf, and knee. EMG data was measured using an eight channel Delsys surface 
electrode system (Delsys, Boston, MA, USA). Electrodes were placed bilaterally on the tibialis anterior 
(TA). Foot/floor reaction forces and moments were measured using three AMTI (Advanced Mechanical 
Technology Inc.; Watertown, MA, USA) six-component force plates. A biaxial custom-built load cell was 
used to measure the tensile force in the cable attached to the waist harness. Analog data was sampled at 
1000 Hz using a 16-bit A/D data acquisition system. 
Analysis: Force plate and load cell data were filtered using a second order low pass Butterworth 
filter with a cutoff frequency of 20 Hz. Initial and final-time artifacts were minimized using forward and 
backward reflection of the data (Smith, 1989), and phase shift was eliminated by using forward and 
backward passes(Winter, 1990). Data from all trials were processed using MATLAB (Mathworks, Natick, 
MA, USA). Trials were classified as single or multiple step trials. A step was defined if the foot lifted off 
the force plate and repositioned to change the base of support. A step less than 50 mm in length was 
defined as a base-width neutral step.  
The purpose of this study was to understand and quantify the use of the base-width neutral step as 
a strategy for balance recovery, and to understand the effects of this strategy on balance recovery.  
The number of steps used in the response was determined by visual inspection of the video 
recording of the trial. A threshold method was used to determine step foot liftoff and landing times. Step 
duration was defined as the time between liftoff and landing. Step length was defined as the distance 
between the location of the heel marker at liftoff and landing. Step height was defined as the maximum 
vertical position of the heel marker between liftoff and landing.  
Time to balance recovery was determined by 1) estimating the position of the center of mass, and 
2) determining when balance recovery occurred. The position of the center of mass was approximated by 
double integration of the lateral ground reaction forces (Gutierrez-Farewik, Bartonek, & Saraste, 2006; 
Lafond, Duarte, & Prince, 2004; Whittle, 1997). The constants of integration were the initial position 
(assumed to be in the same position as the COP at the instant of disturbance onset) and initial speed of the 
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center of mass (assumed to be zero). To reduce error, COM speed data was detrended before integrating 
the second time (Gutierrez-Farewik et al., 2006; Whittle, 1997). Balance recovery was defined as the time 
that the direction of the COM movement changed from backwards to forwards. Time to balance recovery 
was defined as the time between balance recovery and disturbance onset. The center of mass position at 
balance recovery was defined as the AP position of the COM at balance recovery. Figures 5.8 and 5.9 
depict the AP COM trajectory and time of balance recovery for all strategy types.  
Three strategy categories were defined: single step (SS): recovered balance by taking only one 
step, multiple step (MS): recovered balance by taking 2 or more steps, and the base-width neutral step 
(BNS): recovered balance by taking 2 or more steps, the first of which was a very small (less than 50mm) 
step. The step characteristics (step length, height, and duration) and balance recovery parameters (time to 
balance recovery and AP COM position at balance recovery) were compared for each group.  
Statistical Analysis: In order to determine the effect of strategy (single step, multiple step, or use 
of a base-width neutral step), step characteristics and recovery parameters were compared across the three 
different categories in each group using a linear mixed model with subject as a random factor and a 
variance components covariance structure. Post-hoc tests between groups were done and a Bonferonni 
correction for multiple comparisons was applied for each set of comparisons.  
The first groups to be compared were HC vs. PD, with all stepping strategies grouped together 
(N=10 in each group). Shapiro-Wilk’s tests were used to verify the assumption of normal distribution on 
all parameters. If the assumption was violated, the Mann-Whitney test for independent samples was used 
to determine group differences. If the assumption was confirmed, independent samples t-tests were used 
to determine group differences between the remaining outcome parameters for each specific aim.  
Next, single and multiple step trials were separated into either a single or multiple step categories 
within the PD and HC groups and the resulting 4 groups were compared using the linear mixed model 
(HC single step (N=7), HC multiple step (N=7), PD single step (N=4), PD multiple step (N=9)). Note that 
each subject could have a trial in more than one category. Finally, the PD multiple step group was further 
divided into a category of subjects with a BNS as the first step, and the five groups were compared (HC 
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single steps (N=7), HC multiple steps (N=7), PD single steps (N=5), PD multiple steps (N=8), and PD 
BNS (N=6)).  
Results 
Ten people with PD and ten HC completed the study. Anthropometric (age, weight and height), 
initial stance (stance width, initial COP location, initial force distribution) and pull characteristics (peak, 
duration, impulse) revealed no group differences and were not considered further (Table 5.2). 
All participants regained balance by taking at least one step, and were not necessarily consistent 
in strategy type over the three trials. The breakdown of subjects with at least one trial in a strategy 
category was as follows: single steps: 7 HC and 5 PD, multiple steps: 7 HC and 8 PD, BNS steps: 0 HC, 6 
PD. One PD participant used a BNS step in each of the three trials, and one PD participant used a single 
step response in each of the three trials.  
Effects of Moderate PD on Step Characteristics: Participants with moderate PD used a 
significantly shorter first step in terms of length, height, and duration as shown in Figure 5.1 (Step 
Length: PD: 96.7 ± 55.2 mm, HC: 222.0 ± 139.8 mm, p=.000, Step Height: PD: 28.3 ± 21.4 mm, HC: 
59.0 ± 38.3 mm, p= .002, Step Duration: PD: 111.4 ± 36.3 ms, HC: 176.0 ± 62.9, p = .000).  
Effects of Multiple Step Strategy on Step Characteristics: Results in the following two sections 
are presented as estimated group means ± standard error, as calculated in the linear mixed model. There 
was a significant main effect for group on all step parameters (Step Length: p= .001, Step Height: p=.008, 
Step Duration: p= .001). Step characteristics for each group are presented in Figure 5.2. Pairwise tests 
revealed group differences between the single step responses in the HC group compared to other response 
groups. For instance, single step responses in the healthy control group were significantly longer in length 
than any other group (HC SS: 274.8 ± 33.6 mm; HC MS: 185.7 ± 31.4 mm, p= .018; PD SS: 123.5 ± 34.8 
mm, p= .024; PD MS: 87.0 ± 28.7 mm, p = .002). Single step responses in the healthy control group were 
also significantly larger in both height (p= .008) and duration (p= .001) compared to the first step in the 
multiple step responses in the PD group. Finally, single step responses in the healthy control group were 
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also shorter in duration compared to the PD single step group (p= .034). In addition, a trend towards 
smaller, shorter steps in the PD multiple step group compared to the HC multiple step group was present, 
but was not significant after the Bonferroni correction. The single step responses in the PD group were 
not significantly larger or longer than the first step in a multiple step response within the PD group.  
Effects of a Base-width Neutral Step as the First Step in the Response: The use of a base-width 
neutral step (BNS) was defined if the first step in the response was less than 50mm in length. This 
strategy was observed in 9 trials across 6 PD participants, and never observed in the control group. 
Characteristics of this BNS are shown compared to other step strategies in Figure 5.3. There was a 
significant main effect for group on all step parameters (Step Length: p= .000, Step Height: p= .002, Step 
Duration: p= .000). Pairwise tests revealed several group differences in the base-width neutral step 
compared to the other step strategies. For instance, the base-width neutral steps were significantly smaller 
in both length and height, and shorter in duration compared to the HC SS group (Step Length: PD BNS: 
41.6 ± 32.0 mm, HC SS: 273.9 ± 32.4 mm, p= .000; Step Height: PD BNS: 10.1 ± 10.3, HC SS: 73.0 ± 
10.1, p= .000; Step Duration: PD BNS: 77.0 ± 16.1 ms, HC SS: 194.1 ± 14.9 ms, p= .000). BNS steps 
were also significantly shorter in length and duration compared to HC MS (Step Length: PD BNS: 41.6 ± 
32.0 mm, HC MS: 186.4 ± 30.4, p= .03, Step Duration: 77.0 ± 16.1 ms, HC MS: 160.1 ± 14.4, p= .01). 
Finally, BNS steps were significantly shorter in duration compared to PD MS (PD BNS: 77.0 ± 16.1 ms, 
PD MS: 122.9 ± 14.4, p= .03). Several other trends existed in step parameters between strategy 
categories, but they did not reach significance after the Bonferroni correction.  
Further investigation of the use of the BNS showed that 3/6 of the participants who used a base-
width neutral step used it on the first of the three trials. Two of those participants did not use a BNS 
again, while one of those participants used it on all three trials. In addition, 5/6 of the participants who 
used a base-width neutral step used the less-affected side to take the base-width neutral step, while only 
one participant took the BNS with the more affected side.  
Effects of Moderate PD on Balance Recovery Parameters: Participants with moderate PD, 
compared to HC, used significantly more steps to regain balance (PD: 2.73 ± 1.33, HC: 1.67 ± 0.71, p= 
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.001) and had significantly longer time to balance recovery than HC (PD: 1639 ± 475 ms, HC: 1347 ± 
283 ms, p= .006) but the center of mass was not significantly further posterior at the time of balance 
recovery (PD: 382 ± 312 mm, HC: 317 ± 128 mm, p = .767), as shown in Figure 5.4. 
Effects of Multiple Step Strategy on Balance Recovery Parameters: Results in the following two 
sections are presented as estimated group means ± standard error, as calculated in the linear mixed model. 
There was a significant main effect for group on recovery time (p = .000), but not for the AP position of 
COM at recovery (p= .142). Pairwise tests revealed a significant difference between the PD MS group 
compared to all other groups in recovery time as shown in Figure 5.5 (PD MS: 1794 ± 74.6 ms, PD SS: 
1214 ± 124 ms, p= .000; HC MS: 1312 ± 87.5 ms, p= .000; HC SS: 1387 ± 93.5 ms, p= .008). The 
position of the center of mass at recovery time trended towards being further back in the PD MS group 
compared to all other groups, but this result did not reach significance after the Bonferroni correction.  
Effects of a Base-width Neutral Step as the First Step in the Response: There was a significant 
main effect for group on recovery time (p= .000), but not for AP COM position (p= .09). Pairwise tests 
revealed a significant difference between the PD BNS group compared to the PD SS group, HC MS 
group, and HC SS group in recovery time as shown in Figure 5.6 (PD BNS: 1993 ± 112 ms, PD SS: 1214 
± 119 ms, p= .000; HC MS: 1312 ± 84.3 ms, p = .000; HC SS: 1387 ± 90.1 ms, p = .000). In addition, 
recovery time was significantly longer in the PD MS group compared to the PD SS group (PD MS: 1656 
± 93.5 ms, PD SS: 1214 ± 119 ms, p = .05). The position of the center of mass at recovery time was 
furthest back in the PD BNS group, but this result did not reach significance after the Bonferroni 
correction.  
Clinical Scores not significantly related to Strategy Type: None of the clinical UPDRS measures 
investigated (total UPDRS score, UPDRS motor score, and UPDRS PIGD sub-section were significantly 
different between PD participants who never used a BNS compared to PD participants who used a BNS in 
at least one trial. There was a trend towards higher total UPDRS and UPDRS motor scores, but not to a 
significant level (Figure 5.7). In addition, we saw no correlation between fall history and the use of a 
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BNS. In fact, only two of the participants reported no history of falls (i.e. non fallers), and both of these 
participants used a BNS response in one trial.  
Discussion 
The purpose of this study was to examine the effect of response strategy on balance recovery and 
to characterize the base-width neutral step (BNS). Maki et al. reported the use of a BNS in response to 
lateral perturbations, but did not quantify the characteristics or frequency of use of this step in older adults 
compared to young adults (Maki, Edmondstone, & McIlroy, 2000).  
Effects of PD and strategy on step characteristics: In general, the single stepping strategy in the 
HC group had longer step lengths, duration, and height than the other stepping strategies in either group. 
Step length for single steps in the HC group was longer than any other stepping strategy in either group. 
This is consistent with previous findings of small step length in PD during compensatory stepping 
(Burleigh-Jacobs, Horak, Nutt, & Obeso, 1997; Jacobs & Horak, 2006; Maki & McIlroy, 2005). The 
base-width neutral step was, by definition, shorter in length than other stepping strategies. It was also 
shorter in duration compared to all other strategies in both groups, and shorter in height compared to the 
HC SS group.  
Effects of PD and Step Strategy on Balance Recovery: Patients with PD took significantly longer 
to recover balance. When the groups were separated into SS and MS strategy groups, it appears that this 
increase is primarily attributed to the multiple step responses, as the PD MS strategy category took 
significantly longer to recover balance compared to every other category. Subdividing the groups once 
more to separate the PD BNS strategy category, we see that some, but not all, of this difference can be 
attributed to the use of the BNS as a first step in the response, as this group took significantly longer to 
recover compared to every group except the PD MS group. Interestingly, no significant differences were 
found in the AP position of the COM at recovery time, although it trended towards being further back in 
the PD MS and PD BNS categories compared to both HC categories and the PD SS category.  
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Finally, the PD SS group recovered balance the fastest and with the least backwards movement of 
their COM, likely due to the smaller step used compared to the HC groups. If a single step strategy, even 
considering the smaller step, is the most efficient at recovering balance, that may provide one potential 
target of step training and physical therapy in PD.  
Use of BNS as a strategy for balance recovery in PD? Several questions arise regarding the use 
of the BNS as a first step in the response. Previous studies have shown that PD patients were more likely 
to use an anticipatory postural adjustment (APA), and even sometimes used multiple APAs in preparation 
for a compensatory step, resulting in longer liftoff times and the use of significantly more and shorter 
steps to regain balance (King et al., 2010); McVey, et al. (2008), where healthy controls never used 
multiple APAs. One question for further exploration is whether the use of this BNS is an evolution of the 
multiple APA phenomenon, that is, are participants who may have used multiple APAs earlier in the 
disease progression now using a BNS instead? At what cost and what benefit? From this study, it appears 
that the cost of using a BNS is a longer time to balance recovery. However, the use of a BNS does not 
result in the COM moving further back at recovery time.  
We know that with age, responses to balance disturbances change: older adults use smaller, 
multiple steps to respond to a balance disturbance where young adults use a single larger step (Luchies, 
Alexander, Schultz, & Ashtonmiller, 1994; Maki & McIlroy, 2005; McIlroy & Maki, 1996). As balance 
further deteriorates with PD, we start to see the use of multiple APAs. Is the use of the BNS a strategy to 
compensate for the slow response when using multiple APAs, or is it a further deterioration of the 
response? Could it be related to a difficulty in changing set or an un-needed change in set (set refers to the 
state of the nervous system that is determined or influenced by the context of a task (Chong et al., 2000))? 
These questions should be addressed in further studies.  
Finally, in this study we did not see a correlation between fall history or the UPDRS scores and 
the use of a base-width neutral step. This may be due to the small sample size and homogeneity of the PD 
group (selected for the presence of postural instability). Further studies should investigate the presence of 
this strategy in other PD severity groups. 
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Limitations 
This study has limitations. For one, the small sample size and inconsistency in stepping strategies 
used for each participant yield small numbers when further divided by strategy type. In addition, only 
moderate PD was investigated. Further study on this topic should include a mild PD group to better 
understand the evolution of stepping strategies and their effect on balance recovery.  
Conclusions 
Moderate PD significantly increases the time required for balance recovery in response to a 
backwards pull. In addition, the type of strategy used to respond to the disturbance significantly impacts 
this recovery time. Finally, the use of a BNS as the first step in the response is a new response that has not 
been previously documented and significantly increases the time to balance recovery.  
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Sub Age Sex UPDRS UPDRS UPDRS H&Y Duration Medications Dose/Day
Num Motor #33 (yrs) (mg/day)
4002 71 F 47 28 2 3 13 Carbiodopa/Levodopa 600
Carbiodopa/Levodopa ER 200
Pramiprexole 1.5
4004 61 M 36 17 2 3 11 Carbidopa/Levodopa 1200
Entacapone 1200
Rasagiline 1
Ropinirole PR 12
4005 69 M 57 36 2 3 3 Carbidopa/Levodopa 750
Carbidopa/Levodopa ER 100
Ropinirole 9
4006 71 M 47 27 2 3 7 Carbidopa/Levodopa 800
Entacapone 800
Rasagiline 1
Pramipexole 3
Amantadine 100
4007 66 M 35 23 2 3 2 Carbidopa/Levodopa 600
Pramipexole 6
4008 63 M 65 41 2 3 9 Carbidopa/Levodopa 450
Carbidopa/Levodopa ER 200
Ropinirole 6
Amantadine 200
4010 64 M 44 31 2 3 9 Carbidopa/Levodopa 400
Carbidopa/Levodopa ER 800
Ropinirole 6
4011 68 M 53 30 2 3 11 Carbidopa/Levodopa 1000
Ropinirole 9
Amantadine 200
Benztropine 1
4012 72 F 50 33 2 3 8 Carbidopa/Levodopa 800
Carbidopa/Levodopa ER 700
Pramipexole 1.5
4013 72 M 62 41 2 3 5 Carbidopa/Levodopa 400
Amantadine 100/week
Average 67.7 49.6 30.7 2 3 7.8
Std Dev 4.00 10.00 7.56 0.00 0.00 3.58
Table 5.1. Characteristics of PD Participants 
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HC (N = 10) PD (N = 10) p-value
Age (yrs)  68 (5) 68 (4) 0.677
Mass (kg) 75 (13) 85 (19) 0.192
Height (cm) 175 (6) 173 (10) 0.507
Pull Characteristics
Peak (N) 299 (57) 290 (59) 0.737
Duration (ms) 304 (15) 308 (34) 0.682
Impulse/wh (N-s/kg-m) .251 (.04) .232 (.06) 0.456
Initial Stance Characteristics
Stance Width (mm) 231 (38) 248 (63) 0.455
COP AP at Pull (mm) -.312 (1.9) 2.27 (5.37) 0.179
COP ML at Pull (mm) .015 (1.37) .823 (2.76) 0.418
Left Vertical Force at Pull (N) 394 (81) 450 (113) 0.216
Right Vertical Force at Pull (N) 393 (61) 431 (97) 0.241
Table 5.2. Characteristics of Participant Groups, Pull and Initial Stance Characteristics 
 
Participant characteristics, pull characteristics, and initial stance characteristics showed no 
significant differences. Values are mean (standard deviation). P-values are based on t-tests. 
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Comparison of step characteristics in HC group compared to PD group. All response types are included 
(single step, multiple step, base-width neutral step). Bars are means + standard deviation.  * indicates p < .05 
in Mann-Whitney U-Test. AP STL= step length in the anterior-posterior direction, STD= step duration time, 
STH= step height.  
Figure 5.1. Comparison of Step Characteristics in HC Group Compared to PD Group 
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Figure 5.2. Comparison of Step Characteristics in HC And PD Group by Strategy Category 
Comparison of step characteristics in HC and PD group by strategy category. HC SS= healthy 
control single step, HC MS= healthy control multiple step, PD SS= PD single step, PD MS= PD 
multiple step. Bars are means + SE. + indicates pairwise p < .05 after Bonferroni correction based 
on Linear Mixed Model. AP STL= step length in the anterior-posterior direction, STD= step 
duration time, STH= step height. 
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Figure 5.3. Comparison of Step Characteristics in HC and PD Group by Strategy Category 
Comparison of step characteristics in HC and PD group by strategy category. HC SS= healthy 
control single step, HC MS= healthy control multiple step, PD SS= PD single step, PD MS= PD 
multiple step, PD BNS= PD base-width neutral step. Bars are means + SE. + indicates pairwise p 
< .05 after Bonferroni correction based on Linear Mixed Model. AP STL= Anterior-Posterior 
Step Length, STD= step duration time, STH= step height.  
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Figure 5.4. Comparison of Balance Recovery Parameters in HC Group Compared to PD Group 
Comparison of balance recovery parameters in HC group compared to PD group. All 
response types are included (SS, MS, BNS). Bars are means + SE.  * indicates p < .05 based 
on t-test. Rec Time = time to balance recovery, AP COM= position of the center of mass in 
the anterior-posterior direction at time of balance recovery.  
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Figure 5.5. Comparison of Balance Recovery Parameters by Single vs. Multiple Step Strategy 
Comparison of step characteristics in HC and PD group by strategy category. HC SS= healthy 
control single step, HC MS= healthy control multiple step, PD SS= PD single step, PD MS= PD 
multiple step. Bars are means + SE. + indicates pairwise p < .05 after Bonferroni correction in 
Linear Mixed Model. Rec Time = time to balance recovery, AP COM= position of the center of 
mass in the anterior-posterior direction at time of balance recovery. 
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Figure 5.6. Comparison of Balance Recovery Parameters by Strategy Category 
Comparison of step characteristics in HC and PD group by strategy category. HC SS= healthy 
control single step, HC MS= healthy control multiple step, PD SS= PD single step, PD MS= PD 
multiple step, PD BNS= PD base-width neutral step. Bars are means + SE. + indicates pairwise p 
< .05 after Bonferroni correction in linear mixed model. Rec Time = time to balance recovery, AP 
COM= position of the center of mass in the anterior-posterior direction at time of balance 
recovery. 
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Figure 5.7. UPDRS Scores by Strategy Type (use of BNS or no use of BNS) 
UPDRS scores by BNS use. BNS= base-width neutral step used as first step in response. 
UPDRS= Unified Parkinson’s Disease Rating Scale, PIGD= Postural instability and Gait 
Disorder subsection of UPDRS. 
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Figure 5.8. Representative Trace of AP COM Trajectory in Multiple Step Strategy Category  
Representative trace of AP COM trajectory in multiple step strategy categories.  Solid black line= 
healthy control multiple step trial, dashed blue line= PD multiple step trial, dotted blue line= PD base-
width neutral step trial. Circle indicates disturbance onset, squares indicate balance recovery time. 
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Figure 5.9. Representative Trace of AP COM Trajectory in Single Step Strategy Category 
Representative trace of AP COM trajectory in single step strategy categories.  Solid black line= 
healthy control single step trial, dashed blue line= PD single step trial. Circle indicates 
disturbance onset, squares indicate balance recovery time. 
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CHAPTER SIX:  SUMMARY 
Summary of Study 
The primary goal of this work was to investigate the effect of moderate Parkinson’s disease on 
compensatory backwards stepping after a balance disturbance. Healthy control (HC) participants and 
participants with moderate Parkinson’s disease (PD) responded naturally to a backwards pull at the waist. 
Video, motion, EMG, force plate, and load cell data were used to quantify the response in terms of 
strategy, temporal, kinematic, kinetic, and center of pressure parameters.  
The first study investigated the overall response to a balance disturbance in moderate PD, looking 
at strategy, temporal, kinematic, and center of pressure parameters during the first step in the response. 
Patients with moderate PD utilized more steps to regain balance, had a longer weight shift time, and the 
use of a base-width neutral step emerged as a strategy used to regain balance. 
The second study further investigated the compensatory response by focusing on the preparation 
phase, specifically looking at the movement of the center of pressure and the use of anticipatory postural 
adjustments prior to liftoff of the first step. Moderate PD significantly affected the preparation for the first 
compensatory step. PD participants used multiple APAs, resulting in longer liftoff times and significantly 
different movement in the center of pressure prior to liftoff compared to healthy controls. Furthermore, 
the differences in the response could be attributed to the stage of preparation prior to final weight shift. 
This portion of the response and these parameters should be further investigated for their value in the 
development of a more sensitive measure of postural instability.  
The third study described the effects of moderate PD on balance recovery time and the position of 
the center of mass at balance recovery, and investigated the effects of step strategy (single step, multiple 
steps, and a base-width neutral step) on balance recovery. Participants with moderate PD took 
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significantly longer to recover balance in response to the backwards pull. In addition, the type of strategy 
used to respond to the disturbance was found to significantly impact the length of the recovery time. 
Finally, the use of a base-width neutral step as the first step in the response emerged as a new response 
that has not been previously documented and significantly delays the length of time required to achieve 
balance recovery.  
Conclusions and Recommendations 
Taken together, the results from these studies suggest that moderate Parkinson’s disease 
significantly impairs the compensatory response to a backwards pull. In particular, participants with 
moderate PD used more steps to regain balance and a longer weight shift time. Furthermore, this 
impairment could be attributed, at least in part, to a delay in the preparation phase of the step response. 
This delay was associated with the use of multiple anticipatory postural adjustments and/or the use of a 
base-width neutral step as the first step in the response. As suggested by other studies, it may be that this 
impairment in preparation for the step is due to the interruption of a pre-planned response that is not 
working fast enough to stabilize the center of mass. It is unclear whether or not these impairments are 
associated with an increased risk of falling, a question which is beyond the scope of the current study. 
Further study should examine the progression of impairment in these compensatory responses across 
severity levels, and the correlation with fall risk.  
Limitations and Future Work 
This study has limitations. For one, subjects were only tested in the ON medication state. We do 
not have data to describe the effects of medication on this response. However, the long-term goal of this 
research is to determine biomechanical tests that can be adapted for clinical use, in which case the patients 
would be tested on their normal medication. Another limitation of this study is the small sample size, 
particularly when groups were further divided based on preparation strategy. It is noted that the linear 
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mixed model analyses are exploratory, and care has been taken to be conservative in interpretation of all 
results.  
Future studies must address several questions. First, how do the responses in moderate PD 
correspond to other disease severity levels, specifically mild PD? Are the differences seen in these studies 
a further deterioration of the response in mild PD or are the changes in strategy such as the use of a base-
width neutral step a compensatory strategy developed as PD progresses? The progression of these 
changes in compensatory strategies must be further explored. Second, how do these changes in 
compensatory response correlate to postural instability and fall risk? Finally, is there a biomechanical 
measure or a set of measures that can add more sensitivity and specificity to the current clinical 
evaluation of postural instability in Parkinson’s disease, and if so, how can the quantitative measures be 
translated to the clinic?  
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APPENDIX A : DETAILED DESCRIPTION OF OUTCOME MEASURE CALCULATIONS 
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Paper 1: Effect of Moderate Parkinson’s Disease on the Step Response to a Backwards Pull 
Strategic Parameters: Qualitative differences in the strategy used to recover from the balance 
disturbance were determined by analyzing video recorded during the trials. Parameters extracted from the 
video recordings include: the number of steps taken to regain balance, utilization of a single or multiple 
step response, and the foot used for the first step (right or left). A participant was defined as a multiple 
step user if a multiple step response was used to regain balance in any of the three trials. A participant 
was classified as being step foot consistent if the same foot was used for the first step in all three trials. A 
trial was defined as a change-in-the-base-of-support if the foot lifted off the force plate and repositioned 
to change the base of support. The foot was required to translate 50mm or more (as calculated by the 
difference in position between liftoff and landing of the heel marker) in order to be considered a step.  
Data Conditioning: Analog data (force plate, load cell, and EMG) were first zeroed by 
subtracting off the mean of a 1 second zero trial, taken just prior to the start of data collection. Then data 
was filtered with a second-order low pass Butterworth filter with a cutoff frequency of 20 Hz for the force 
plate signal and 50 Hz for the EMG signals and load cell signals.  
Coordinate Systems: All force plate data was rotated to coincide with the global coordinate 
system for the optotrak system (see Figure A-1). The origin of the global coordinate system was at the 
back right corner of the back force plate, with positive X pointing anterior and positive Y pointing medial 
when standing on the back force plate facing north.  
Temporal Parameters: A threshold method was used to determine four temporal events 
(disturbance onset, EMG onset, and step foot liftoff and landing times) which were used to define the 
temporal parameters reaction time, weight shift time and step duration. The following parameters and 
definitions were used.  
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Disturbance onset: The cable pull force was measured using a bi-axial load cell. Disturbance onset 
(LC_onset) was defined as the time when the total load cell force exceeded the threshold. The total load 
cell force was taken as  
               √          
                   
The load cell threshold was defined as the mean plus 10 standard deviations of the signal over the 
first 500ms of data collection.  
Muscle onset: EMG signals for the right and left Tibialis Anterior (TA) muscle were analyzed. Signals 
were full-wave rectified, the mean was subtracted, and then the signal was low pass filtered with a cutoff 
frequency of 50 Hz. The EMG threshold value was defined as the mean plus five standard deviations of 
the signal over a 50 ms window prior to the disturbance. Muscle onset (EMG_on) was defined as the first 
time 25 consecutive EMG data points exceeded the threshold in either the right or left muscle, whichever 
happened first. 
Reaction time (RT): time between disturbance onset and first TA muscle onset.  
                             
Liftoff time (LT): time between disturbance onset and unloading of the vertical force component under the 
foot used for stepping, when the vertical force is less than 4% body weight.  
Weight shift time (WST): time between reaction time and liftoff time.  
                           
Landing time (LDT): time between disturbance onset and re-loading of the vertical force component under 
the foot used for stepping, when the vertical force is greater than 4% body weight.  
Step duration (STD): time between landing time and liftoff time.  
                      
Ankle Kinematics: The ankle angle was determined using the measured motion data with the kinematics 
portion of Vaughn’s 3D inverse dynamics model. The segments used were the right and left foot and calf. 
First, unit vectors for each segment were determined based on marker placement, and joint centers for the 
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toe, ankle, and knee were established based on anthropometrics and the unit vectors. Next, a segment 
reference frame was determined for the calf and foot using the joint centers and the appropriate markers. 
Finally, the plantarflexion angle was determined as the angle between the calf and foot segments (see 
Appendix B for details on kinematic model). 
The peak ankle plantarflexion/dorsiflexion angle during the initial stage of the response (prior to 
liftoff) and the angle at liftoff of the first step was extracted and expressed relative to the initial 
configuration. The excursion was taken as the maximum plantarflexion plus the maximum dorsiflexion. 
The initial angle was taken as the mean of the angle for the 50ms prior to disturbance onset.  
Center of Pressure (COP) Displacement: The anterior-posterior (AP) and medial-lateral (ML) 
COP locations were calculated as a function of time using the foot/floor reaction forces and moments. 
First, the COP for each individual force plate was calculated using the following equations: 
      
           
  
 
 
      
          
  
 
Where Mx, My, Fx, and Fz are the components of the force plate output, and dz indicates the 
vertical distance from each plate’s surface to its coordinate system origin. In our global coordinate 
system, x indicates the anterior-posterior direction and y indicates the medial-lateral direction. At this 
point all force plates have the same coordinate system orientation (the global orientation). Next, the force 
plate coordinate systems need to be translated to coincide with the global origin using measurements of 
the distance between each individual force plate origin and the global origin, using the method outlined 
by Kistler (see figure A-2). 
The whole-body COP location was analyzed from disturbance onset time to landing of the first 
step. The AP and ML displacements of the COP were determined at liftoff and landing of the first step 
relative to the COP location at disturbance onset.   
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Figure 6.1. Illustration of Laboratory Coordinate Systems 
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Schematic of Laboratory Coordinate Systems. Lower-case letters represent force plate local coordinate 
systems, bold capital letters represent Optotrak global coordinate system.   
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Figure 6.2. Description of Method to Calculate COP from Multiple Force Plates 
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Paper 2: Preparation for Compensatory Backwards Stepping in Moderate Parkinson’s Disease 
Data Conditioning: Analog data (force plate, load cell, and EMG) were first zeroed by 
subtracting off the mean of a 1 second zero trial, taken just prior to the start of data collection. Then data 
was filtered with a second-order low pass Butterworth filter with a cutoff frequency of 20 Hz for the force 
plate signal and 50 Hz for the EMG signals and load cell signals.  
Coordinate Systems: All force plate data was rotated to coincide with the global coordinate 
system for the optotrak system (see figure A-1). The origin of the global coordinate system was at the 
back right corner of the back force plate, with positive X pointing anterior and positive Y pointing medial 
when standing on the back force plate facing north.  
Center of Pressure (COP) Parameters: The anterior-posterior (AP) and medial-lateral (ML) COP 
locations were calculated as a function of time using the foot/floor reaction forces and moments. First, the 
COP for each individual force plate was calculated using the following equations: 
      
           
  
 
 
      
          
  
 
Where Mx, My, Fx, and Fz are the components of the force plate output, and dz indicates the 
vertical distance from each plate’s surface to its coordinate system origin. In our global coordinate 
system, x indicates the anterior-posterior direction and y indicates the medial-lateral direction. At this 
point all force plates have the same coordinate system orientation (the global orientation). Next, the force 
plate coordinate systems need to be translated to coincide with the global origin using measurements of 
the distance between each individual force plate origin and the global origin, using the method outlined 
by Kistler (see figure A-2). 
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Definition of Response Stages: This paper focused on the preparation phase of the response- prior 
to liftoff of the first step. So, the whole-body COP was analyzed from disturbance onset until liftoff of the 
first step. Within this phase, two stages were defined. The first phase was defined as disturbance onset 
until the start of the final weight shift, and phase two was defined as from the start of final weight shift to 
liftoff of the first step. The start of final weight shift was defined as the last time the ML COP changed 
direction, and was calculated by looking for the last change in sign of the derivative of the ML COP 
signal. The following parameters were calculated for each stage: 
COP Path Length: Path length was defined as the total distance traveled by the COP and 
calculated as the sum of the difference in location of each point in the COP in each direction, as below 
where m is taken as the length of the COP vector.  
                ∑                    
     
   
 
 
                ∑                    
     
   
 
 
COP Displacement: COP displacement was defined as the difference in COP location between the start 
and end of each stage.  
Duration: Duration of each stage was calculated as the time between the start and end of each stage.  
Average Velocity: The average velocity of the AP and ML COP was calculated as the path length divided 
by duration of the stage.  
Anticipatory Postural Adjustments: Anticipatory postural adjustments were defined similarly to the 
method in Jacobs and McIlroy. APAs were determined by looking at the ML COP signal from 500 ms 
prior to onset of the disturbance to liftoff of the first step. The baseline signal was defined by the average 
of the signal for 500 ms prior to onset of the disturbance. Local maximums and minimums were defined if 
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the ML COP traveled more than 1 cm from the baseline. Each maximum and minimum indicated the 
presence of an APA. However, two rules were established to prevent incorrectly identifying additional 
APAs: a subsequent APA was required to be in the opposite direction of the first, and an APA was not 
counted if the local maximum or minimum occurred just prior to liftoff. Visual inspection verified the 
Matlab-counted APAs, and trials were classified as having 0, 1, or 2 or more APAs.  
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Paper 3: The Effect of the use of a Base-Width Neutral Step on Balance Recovery in Parkinson’s 
Disease 
Data Conditioning: Analog data (force plate, load cell, and EMG) were first zeroed by 
subtracting off the mean of a 1 second zero trial, taken just prior to the start of data collection. Then data 
was filtered with a second-order low pass Butterworth filter with a cutoff frequency of 20 Hz for the force 
plate signal and 50 Hz for the EMG signals and load cell signals.  
Coordinate Systems: All force plate data was rotated to coincide with the global coordinate 
system for the optotrak system (see Figure A-1). The origin of the global coordinate system was at the 
back right corner of the back force plate, with positive X pointing anterior and positive Y pointing medial 
when standing on the back force plate facing north.  
Center of Pressure (COP) Parameters: The anterior-posterior (AP) and medial-lateral (ML) COP 
locations were calculated as a function of time using the foot/floor reaction forces and moments. First, the 
COP for each individual force plate was calculated using the following equations: 
      
           
  
 
 
      
          
  
 
Where Mx, My, Fx, and Fz are the components of the force plate output, and dz indicates the 
vertical distance from each plate’s surface to its coordinate system origin. In our global coordinate 
system, x indicates the anterior-posterior direction and y indicates the medial-lateral direction. At this 
point all force plates have the same coordinate system orientation (the global orientation). Next, the force 
plate coordinate systems need to be translated to coincide with the global origin using measurements of 
the distance between each individual force plate origin and the global origin, using the method outlined 
by Kistler (see figure A-2). 
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Estimation of Center of Mass: The position of the center of mass was approximated by double 
integration of the lateral ground reaction forces: 
 ⃗   ∫
 ⃗
 
     
 ⃗  ∫  ⃗      
Where F= the horizontal GRFs, m is the mass of the participant, v is the velocity of the center of 
mass, p is the position of the center of mass, vo is the initial velocity of the COM, assumed to be zero at 
disturbance onset, and po is the initial position of the center of mass, assumed to be equal to the COP at 
load cell onset. To combat against amplification of noise, data was detrended after the first integration.  
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APPENDIX B : KINEMATIC MODEL DETAILS1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
Modified from Vaughan, C.L., B.L. Davis, and J.C. O’Connor, Dynamics of Human Gait. 1992, 
Champaign, IL: Human Kinetics Publishers. 
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APPENDIX C : RECRUITMENT AND TESTING MATERIALS 
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Health Screen- Healthy Controls 
Subject Identification Number: 
 
Date of Screen: 
 
Subject name:   ________________________________________________                                                                                                    
  Last    First   
 
“My name is _____.  I am calling from the Biodynamics Laboratory at the University of Kansas.  
I was given your name as someone who had indicated an interest in participating in a research study.  We 
are now beginning a study looking at how the brain controls our balance and how that might be related to 
risk of falling. If you think you might be interested in participating, and you have a few minutes, I’d like 
to describe the study to you.”   
 
Is subject interested?        YES NO 
 Comments:_____________________________________________________ 
 ______________________________________________________________ 
 
If NO:  “Thank you for your time.  Would you be interested in being contacted for future studies 
or do you prefer that your name is removed from our list?” 
 Comments:________________________________________________________
 _________________________________________________________________ 
 
If YES: “Please feel free to ask questions at any time. This study is a one-time evaluation that 
will look at how Parkinson’s disease affects the ability of the brain to control our balance. We will be 
looking at those with Parkinson’s compared to healthy adults in the same age range.  There are two parts 
to this study. First, there is a medical screening procedure.  The first part is done over the phone and will 
take approximately 20 minutes. This will include questions about current and previous health conditions. 
Once that is completed we will schedule you for a visit to the Biodynamics Laboratory at KU in 
Lawrence where we will do a physical assessment that and then do the balance testing. For the balance 
testing, we will ask you to do four different tests: one that just involves standing still, one that involves 
starting to walk from rest, one that involves walking on a treadmill for about 5 minutes, and a balance 
recovery test.  For the balance recovery test, we will pull you backwards from the waist and you will have 
to regain your balance. During all of the tests, you will be wearing a protective harness to ensure your 
safety. The whole test will take approximately 3 hours. There is no cost for participating in this study, nor 
are there any direct benefits to you.  We will pay you $30 for your participation. If you are still interested, 
I would like to ask you some questions to see if you would be able to participate in this study.” 
 
Notes:_________________________________________________________________________
________________________________________________________________ 
 
**If subject is excluded by any questions, stop the interview and explain to the subject the reason 
for exclusion.  Thank them for their time and willingness to participate. 
 
Name: ___________________________________ Age:___________________ 
Birthdate:_________________________________________________________ 
Gender:  M F   
Address: __________________________________________________________  
Phone #: 
Address: 
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Phone: ___________________________________________________________ 
Schooling/Occupation: _______________________________________________ 
Height: ________________Weight: ________________________ 
Are you currently participating in any other research studies? 
 
This study will require one trip to the University of Kansas in Lawrence. Would you have 
transportation for this visit? 
 
 
Are you able to get out of bed and also use the bathroom without assistance from anything or 
anyone? 
 
Are you able to stand on your own for 10 minutes without assistance? 
(ex. Can you stand at the bathroom sink to do your morning care without having to hold to 
something?) 
 
 
SUMMARY OF MEDICAL SCREEN: 
 
 
 
  
Pass? If no, why not? 
 
 
 
Height: __________ Weight:__________Age:__________Gender: ____________ 
 
 
 
Comments:  
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Have you been diagnosed 
with: 
Yes No When Details Exclude? 
Ever had major surgery or 
amputation? 
    
Yes if affects legs, not 
recovered completely 
Osteoporosis     Yes 
Brittle Bones     Yes 
Fibromyalgia? Constant 
aches and fatigue? 
    Yes if constant 
Arthritis     Yes if in legs 
Nerve Damage     Yes if in legs 
Heart Attack     Yes 
Heart Disease or problems 
(surgeries, valve 
replacement, angina, 
pacemaker?) 
    Yes 
Chest Pain from heart 
disease? 
    Yes 
Polio or Post Polio 
Syndrome 
    Yes 
Broken Bones? 
Compression fractures? 
    
Yes if < 2 years ago 
and in leg or spine 
Ever had a hip, knee, or 
ankle replacement or 
surgery? 
    Yes 
Ever had a joint fusion?     Yes 
Diabetes? Thyroid 
conditions? 
    
Yes if not controlled or 
if have neuropathy 
High Blood Pressure     
Yes if not controlled 
on meds 
Neurological Disease (MS, 
ALS, Dementia, Seizure 
disorders, PD) 
    Yes 
Stroke or TIA     Yes 
Cancer, Leukemia, 
Lymphoma? 
    
Yes if currently being 
treated 
Anemia     
Yes if has had blood 
transfusion in last year 
Seizure     Yes 
Meniere’s Disease? Inner 
Ear Damage? Vertigo? Ear 
infection now? 
    Yes 
Acoustic Neuroma? 
Tinnitus? (ringing, 
buzzing in ears) Do you 
feel pressure in ears? 
    Yes if constant 
 
Do you have any problems 
with: 
Yes No How does it affect ADL? Exclude? 
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Pain or stiffness in hips? 
Knee? Ankles? Back? 
Shoulder? 
   
Yes if affects walking, 
standing 
Hip, Knee, or Ankle 
injury? 
   
Yes if affects walking, 
standing 
Back Problems? If yes: 
What motions cause pain 
(bending, twisting, lifting, 
quick movements?) 
How irritable is the pain? 
How do you treat the pain? 
Have you seen a doctor? 
   
Yes if brought on by 
walking, standing, 
quick movements, if 
brought on easily 
Muscle Problems in leg? 
Weakness in legs? Does it 
limit how far you can walk 
or how long you can 
stand? 
   
Yes if affects walking, 
standing 
Poor circulation in legs 
causing them to become 
cold, numb, or causes 
cramping while walking, 
been diagnosed with 
PVD? Claudication? 
   
Only if causes 
problems when 
walking or standing 
Lung disease? 
Emphezema? Chronic 
Bronchitis? SOB? DOE? 
   
Yes if affects walking, 
standing 
Ever had a head or neck 
injury? 
   Not necessarily 
Gout or Psuedogout?    Not necessarily 
Foot problems?    Not necessarily 
Hearing Problems? 
Hearing aid? Last hearing 
exam? 
   Not necessarily 
Have you been 
hospitalized in the past 
year? Major illness in last 
year? 
   Not necessarily 
Headaches    Not necessarily 
Neuropathy    Not necessarily 
Vision    Not necessarily 
Falls    Not necessarily 
Driving    Not necessarily 
Night Driving    Not necessarily 
Shortness of Breath    Not necessarily 
Edema (swelling of legs)    Not necessarily 
Fainting or 
lightheadedness? 
   Not necessarily 
Memory    Not necessarily 
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Burning pain or weakness 
anywhere 
   Not necessarily 
Depression    Not necessarily 
 
MEDICATIONS: 
What medications are you currently taking? 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
OTC Medications: 
 
 
ACTIVITY: 
Are you able to leave house / apartment on your own? How often? 
___________________________________________________________ 
 
When you walk, do you walk with : Self walker/cane  person assist unable 
How far do you walk on a daily basis? ________ 
How often do you walk? _______ 
How long do you walk (duration) _______ 
 
Do you participate in any exercise/Activities? 
Type ________________________________________________ 
Sessions per week _____________________________________ 
Minutes / hours per session _______________________________ 
 
When you transfer from a sitting to standing position, do you do it:  
Alone With assistive device With person assist Unable 
 
When you transfer from lying down to sitting, do you do it: 
Alone With assistive device With person assist Unable 
 
Hand dominance L R  Leg dominance L R 
(Are you right or left-handed?)  (Which leg would you kick a ball with?) 
 
Recent vision screen? If yes, when? 
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BARTHEL INDEX: SEE FULL VERSION 
       With Help  Independent 
1. Feeding       5   10 
2. Moving from wheelchair to bed and return   5-10   15 
3. Personal toilet (wash face, comb hair, etc.)   0   5 
4. Getting on and off toilet (handling clothes, flush, wipe) 5   10 
5. Bathing self       0   5 
6. Walking on level surface     10   15 
7. Ascend and descend stairs     5   10 
8. Dressing (includes tying shoes, fastening)   5   10 
9. Controlling bowels      5   10 
10. Controlling bladder      5   10 
Is there anything else you can think of about your current or past health state that we might need to know?  
 
“With these initial questions it appears that you are eligible for the next step in the study.  The next step 
involves a physical evaluation by a physical therapist and geriatrician here at the Center on Aging.  The 
evaluation will take approximately one hour.  We are now scheduling participants for ______________.  
Would you be able to come to the Center on Aging to participate during this time?” 
 
If NO: “We will be continuing to test more participants in the coming weeks and months.  Can we contact 
you to schedule a time in future?”   
   
“We like to schedule to start in the morning or after lunch around 1:00…..*schedule a time with them. 
 
Is participant interested? 
 a. Visit scheduled _________________________________________ 
 b. Visit delayed (specify reason)______________________________ 
 c. Subject requests delay and reinquiry at a later date: _____________ 
 d. Subject and/or family expresses wish for no further contact. 
 
Notes: 
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Health Screen For PD Participants 
 
Subject Identification Number: 
 
Date of Screen: 
 
Subject name:   ________________________________________________                                                                                                    
  Last    First   
 
“My name is _____.  I am calling from the Biodynamics Laboratory at the University of Kansas.  
I was given your name by Dr. Lyons and Dr. Pahwa in the Parkinson’s Disease Center at KUMC as 
someone who had indicated an interest in participating in a research study.  We are now beginning a study 
looking at how Parkinson’s disease affects the ability of the brain to control our balance and how that 
might be related to risk of falling. If you think you might be interested in participating, and you have a 
few minutes, I’d like to describe the study to you.”   
 
Is subject interested?        YES NO 
 Comments:_____________________________________________________ 
 ______________________________________________________________ 
 
If NO:  “Thank you for your time.  Would you be interested in being contacted for future studies 
or do you prefer that your name is removed from our list?” 
 Comments:________________________________________________________
 _________________________________________________________________ 
 
If YES: “Please feel free to ask questions at any time. This study is a one-time evaluation that 
will look at how Parkinson’s disease affects the ability of the brain to control our balance. We will be 
looking at those with Parkinson’s compared to healthy adults in the same age range.  There are two parts 
to this study. First, there is a medical screening procedure.  The first part is done over the phone and will 
take approximately 20 minutes. This will include questions about current and previous health conditions. 
Once that is completed we will schedule you for a visit to the Biodynamics Laboratory at KU in 
Lawrence where we will do a physical assessment that and then do the balance testing. For the balance 
testing, we will ask you to do four different tests: one that just involves standing still, one that involves 
starting to walk from rest, one that involves walking on a treadmill for about 5 minutes, and a balance 
recovery test.  For the balance recovery test, we will pull you backwards from the waist and you will have 
to regain your balance. During all of the tests, you will be wearing a protective harness to ensure your 
safety. The whole test will take approximately 3 hours. There is no cost for participating in this study, nor 
are there any direct benefits to you.  We will pay you $30 for your participation. If you are still interested, 
I would like to ask you some questions to see if you would be able to participate in this study.” 
Notes:_________________________________________________________________________
________________________________________________________________ 
 
**If subject is excluded by any questions, stop the interview and explain to the subject the reason 
for exclusion.  Thank them for their time and willingness to participate. 
Phone #: 
Address: 
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Name: ___________________________________ Age:___________________ 
Birthdate:_________________________________________________________ 
Gender:  M F   
Address: __________________________________________________________  
Phone: ___________________________________________________________ 
Schooling/Occupation: _______________________________________________ 
Height: ________________Weight: ________________________ 
Are you currently participating in any other research studies? 
 
This study will be done at the University of Kansas Lawrence Campus. Would you have 
transportation for this visit?  
 
Are you able to get out of bed and also use the bathroom without assistance from anything or 
anyone? 
 
Are you able to stand on your own for 10 minutes without assistance? 
(ex. Can you stand at the bathroom sink to do your morning care without having to hold to 
something?) 
 
 
SUMMARY OF MEDICAL SCREEN: 
 
 
 
  
Pass? If no, why not? 
 
 
 
Height: __________ Weight:__________Age:__________Gender: ____________ 
 
 
 
Comments:  
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Have you been diagnosed with: Yes No When Details Exclude? 
Ever had major surgery or amputation?     Yes if affects legs, not 
recovered completely 
Osteoporosis     Yes 
Brittle Bones     Yes 
Fibromyalgia? Constant aches and 
fatigue? 
    Yes if constant 
Arthritis     Yes if in legs 
Nerve Damage     Yes if in legs 
Heart Attack     Yes 
Heart Disease or problems (surgeries, 
valve replacement, angina, pacemaker?) 
    Yes 
Chest Pain from heart disease?     Yes 
Polio or Post Polio Syndrome     Yes 
Broken Bones? Compression fractures?     Yes if < 2 years ago 
and in leg or spine 
Ever had a hip, knee, or ankle 
replacement or surgery? 
    Yes  
Ever had a joint fusion?     Yes 
Diabetes? Thyroid conditions?     Yes if not controlled 
or if have neuropathy 
High Blood Pressure     Yes if not controlled 
on meds 
Neurological Disease (MS, ALS, 
Dementia, Seizure disorders) 
    Yes 
Stroke or TIA     Yes 
Cancer, Leukemia, Lymphoma?     Yes if currently being 
treated 
Anemia     Yes if has had blood 
transfusion in last year 
Seizure     Yes 
Meniere’s Disease? Inner Ear Damage? 
Vertigo? Ear infection right now? 
    Yes 
Acoustic Neuroma? Tinnitus? (ringing, 
buzzing in ears) Do you feel pressure in 
ears? 
 
    Yes if constant 
Do you have any problems with: Yes No How does it affect ADL? Exclude? 
Pain or stiffness in hips? Knee? Ankles? 
Back? Shoulder? 
   Yes if affects walking, 
standing 
Hip, Knee, or Ankle injury?    Yes if affects walking, 
standing 
Back Problems? If yes: 
What motions cause pain (bending, 
twisting, lifting, quick movements?) 
How irritable is the pain? 
How do you treat the pain? 
Have you seen a doctor? 
   Yes if brought on by 
walking, standing, 
quick movements, if 
brought on quickly 
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Muscle Problems in leg? Weakness in 
legs? Does it limit how far you can walk 
or how long you can stand? 
   Yes if affects walking, 
standing 
Poor circulation in legs causing them to 
become cold, numb, or causes cramping 
while walking, been diagnosed with 
PVD? Claudication? 
   Only if causes 
problems when 
walking or standing 
Lung disease? Emphezema? Chronic 
Bronchitis? SOB? DOE? 
   Yes if affects walking, 
standing 
Ever had a head or neck injury?    Not necessarily 
Gout or Psuedogout?    Not necessarily 
Foot problems?    Not necessarily 
Hearing Problems? Hearing aid? Last 
hearing exam? 
   Not necessarily 
Have you been hospitalized in the past 
year? Major illness in last year? 
   Not necessarily 
Headaches    Not necessarily 
Neuropathy    Not necessarily 
Vision    Not necessarily 
Falls    Not necessarily 
Driving    Not necessarily 
Night Driving    Not necessarily 
Shortness of Breath    Not necessarily 
Edema (swelling of legs)    Not necessarily 
Fainting or lightheadedness?    Not necessarily 
Memory    Not necessarily 
Burning pain or weakness anywhere in 
body? 
   Not necessarily 
Depression    Not necessarily 
 
MEDICATIONS: 
What medications are you currently taking? 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
**Testing should occur 1-2 hours after last dose of medication.  
 
OTC Medications: 
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ACTIVITY: 
Are you able to leave house / apartment on your own? How often? 
When you walk, do you walk with : Self walker/cane  person assist unable 
How far do you walk on a daily basis? ________ 
How often do you walk? _______ 
How long do you walk (duration) _______ 
 
Do you participate in any exercise/Activities? 
Type ________________________________________________ 
Sessions per week _____________________________________ 
Minutes / hours per session _______________________________ 
 
When you transfer from a sitting to standing position, do you do it:  
Alone With assistive device With person assist Unable 
 
When you transfer from lying down to sitting, do you do it: 
Alone With assistive device With person assist Unable 
 
Hand dominance L R  Leg dominance L R 
(Right or left-handed?)   (Which leg would you kick a ball with?) 
 
Recent vision screen? If yes, when? 
 
Is there anything else you can think of about your current or past health state that we might need to know?  
 
When were you first diagnosed with Parkinson’s disease?  
 
What was the first symptom you experienced?  When did you experience the first symptom? 
 
Are you affected on one or both sides of your body? Which side is more affected? 
 
Do you feel like you have bad balance? Do you have difficulty maintaining your balance while: standing 
still, walking, changing positions?   
 
Have you fallen in the past year?  
Event: _______________________Date:________________Injury:_________________ 
Circumstances: ___________________________________________________________ 
Event: _______________________Date:________________Injury:_________________ 
Circumstances: ___________________________________________________________ 
Event: _______________________Date:________________Injury:_________________ 
Circumstances: ___________________________________________________________ 
 
 
How often do you fall? 
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Do you currently use any devices to assist you (canes, walker, etc?) 
 
“With these initial questions it appears that you are eligible for this study.  We are now scheduling 
participants for ______________.  Would you be able to come to the Center on Aging to participant 
during this time?” 
 
If NO: “We will be continuing to test more participants in the coming weeks and months.  Can we contact 
you to schedule a time in future?”   
“We like to schedule to start in the morning or after lunch around 1:00…..*schedule a time with them. 
Is participant interested? 
 a. Visit scheduled _________________________________________ 
 b. Visit delayed (specify reason)______________________________ 
 c. Subject requests delay and reinquiry at a later date: _____________ 
 d. Subject and/or family expresses wish for no further contact. 
 
Notes: 
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Appointment Letter 
October 13, 2010 
Dear, 
 Thank you for agreeing to participate in our research study!  This study looking at how 
Parkinson’s disease affects balance will be conducted in the Biodynamics Lab, which is located on the 
second floor of Learned Hall on the University of Kansas Lawrence Campus. 
Your appointment is scheduled for Wed, Oct. 20
th
 at 3pm and will be about 3
 
hours long. 
Directions and a campus map are included with this letter. Parking is located on the east side of Eaton 
Hall (Learned is adjacent to Eaton Hall), and one of four meters will be hooded and marked “Reserved”- 
this is for you. A research associate will be there to meet you and take you up to the research lab. If you 
have any problems finding anything please give me a call at the number below.  
If you have any questions or need to reschedule your appointment, please contact Molly McVey 
at 785-218-2714.  
Thanks again for participating. 
Sincerely, 
 
Molly McVey 
Graduate Research Assistant  
Biodynamics Laboratory- Mechanical Engineering Department 
The University of Kansas 
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Physical Examination Data 
Height  Weight  
Sitting BP-P   
Supine BP-P Standing BP-P 
Strength Left Right  Left Right 
Shld Abd   Hip Ext   
Biceps   Hip Abd   
Triceps   Hip Add   
Wst Flex   Knee Ext   
Wst Ext   Knee Flex   
Grip   Ankle Df   
Hip Flex   Ankle Pf   
Reflexes   Patellar   
Biceps   Achilles   
Triceps   Babinski   
Sensory Position Vibration Pin Prick 
 Left Right Left Right Left Right 
Upp Ext       
Low Ext       
Cerebellar Left Right 
Fing-Nose   
Heel-Shin   
Other/comments 
 
Examiner Name: ________________________________________________________________________ 
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 MMSE Questionnaire 
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Beck Depression Index  
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Barthel Index 
INSTRUCTIONS: The Barthel Index is a record of what a patient does not a record of what a patient 
could do.  Full credit is not given for an activity if the patient needs even minimal help/supervision.  A 
score of (0) is given when a patient cannot meet the criteria as defined. Circle the appropriate answer to 
each question. 
 
1.  Today, are you able to feed yourself? 
10:  Independent; feeds self from tray or table; can put on assistive device if needed; 
accomplishes feeding in reasonable time. 
5:  Assistance necessary with cutting food, etc. 
0:  Cannot meet criteria 
88:  Contraindicated due to _________________________________________ 
2.  Today, are you able to get out of bed or into a chair? 
 15:  Independent in all phases of this activity 
10:  Minimal help needed or patient needs to be reminded or supervised for safety of 
one or more parts of this activity. 
5: Patient can come to sitting position without help of second person, but needs to 
be lifted out of bed and assisted with transfers 
0:  Cannot meet criteria 
88:  Contraindicated due to _______________________________________ 
3.  Today, are you able to wash your face, brush your teeth, brush your hair, etc.? 
5: Can wash hands, face; combs hair, cleans teeth. Can shave (males) or apply 
makeup (females) without assistance; females need not braid or style hair. 
0:  Cannot meet criteria 
 88:  Contraindicated due to________________________________________ 
4.  Today are you able to get on and off the toilet? 
10:  Able to get on and off the toilet, fastens/unfastens clothes; can use toilet paper without 
assistance.  May use wall bar or other support if needed; if bedpan is necessary, patient can place 
it on chair, empty, and clean it. 
5: Needs help because of imbalance or other problems with clothes or toilet paper 
0:  Cannot meet criteria 
88:  Contraindicated due to _________________________________________ 
 
5.  Today, are you able to bathe yourself? 
5: May use tub, shower, or sponge bath.  Patient must be able to perform all 
functions without another person being present. 
0:  Cannot meet criteria 
88:  Contraindicated due to _________________________________________ 
6.  Today, are you able to walk without help? 
15:  Patient can walk at least 50 yards without assistance or supervision; may use 
braces, prostheses, crutches, canes, or walker, but not a rolling walker. Must be able to 
lock/unlock braces, assume standing or seated position, get mechanical aids into position 
for use and dispose of the mechanical aids when seated (putting on and off braces should 
be scored under dressing). 
10:  Assistance needed to perform above activities, but can walk 50 yards with little 
help. 
0:  Cannot meet criteria 
88:  Contraindicated due to ________________________________________ 
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7.  Today, are you able to use a wheelchair? (Do not score if patient competes score for walking- 
item #6). 
5:  Patient cannot ambulate, but can propel wheelchair independently; can go around 
corners, turn around and maneuver chair to table, bed, toilet, etc; must be able to push 
chair 50 yards. 
0:  Cannot meet criteria 
88:  Contraindicated due to________________________________________ 
8.  Today, are you able to walk up and down stairs? 
10: Able to go up and down flights of stairs safely without supervision; using canes, 
handrails, or crutches when needed and can carry these items as ascending/descending. 
5: Needs help or supervision of any of the above items. 
0:  Cannot meet criteria 
88:  Contraindicated due to ________________________________________ 
9.  Today, are you able to dress and undress yourself? 
10:  Able to put on, fasten, and remove all clothing; ties shoelaces unless necessary 
adaptations used.  Activity includes fastening braces and corsets when prescribed; 
suspenders, loafer shoes, and dresses opening in the front may be used when necessary.   
5: Needs help putting on, fastening, or removing clothing; must accomplish at least 
half of task alone within reasonable time; women need not be scored on use of brassiere 
or girdle undless prescribed. 
0:  Cannot meet criteria 
88:  Contraindicated due to ________________________________________ 
10.  Today, are you able to control your bowels? 
10:  Able to control bowels and have no accidents.  Can use a suppository or take an 
enema when necessary (as for spinal cord injury patients who have had bowel training). 
5: Needs help in using a suppository or taking an enema or has occasional 
accidents. 
0:  Cannot meet criteria 
88:  Contraindicated due to _______________________________________ 
11.  Today, are you able to control your bladder? 
10:  Able to control bladder day and night. Spinal injury patients must be able to put 
on external devices and leg bags independently, clean and empty bag, and must stay dry 
day and night. 
5:  Occasional accidents occur, cannot wait for bedpan, does not get to toilet in time 
or needs help with external device. 
0:  Cannot meet criteria 
88:  Contraindicated due to ________________________________________ 
12. Information for today’s Barthel data gathered from: 
 01: Patient 
 02: Proxy- Caregiver 
 03: Proxy- Other 
 04: Chart 
 05: Both patient and proxy  
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Environmental Assessment 
1. Do you live in a home, apartment, or assisted living facility? 
 
2. Do you have stairs in your home? How often do you use them? 
 
Staircase #1: _______________________ Frequency: _______________________ 
Staircase #2: _______________________ Frequency: _______________________ 
Staircase #3: _______________________ Frequency: _______________________ 
Staircase #4: _______________________ Frequency: _______________________ 
 
3. Do you live alone? With a spouse or partner? Do you have a caretaker (live-in or otherwise)? 
 
4. Do you use any type of assistive devices at any time during a normal day? (Walkers, canes, etc?) 
 
5. Do you ever use assistance from someone else during a normal day? (Taking a hand to go down 
steps, get out of a car, etc.)? 
 
6. Have you ever modified anything in your home to reduce the risk of falling? When? 
 
Modification: __________________________ Date: ________________________ 
Modification: __________________________ Date: ________________________ 
Modification: __________________________ Date: ________________________ 
Modification: __________________________ Date: ________________________ 
Modification: __________________________ Date: ________________________ 
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UPDRS Assessment 
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Technical Setup and Data Acquisition Protocol 
Data Acquisition Setup 
Setup data files on both the labview and optotrak computers.  For the labview computer, setup a folder for 
each subject in each task folder. My documentsResearchMollyPD Project 2010DataBR, GI, 
Sway, Gait, etc. For the optotrak computer, just setup a subject folder in the PD ProjectData folder. It is 
imperative to keep track of which optotrak file goes with which data file from the other computer. I 
usually do this on the data collection sheet.  
Decide the order of tasks for the experiment and order of EO/EC trials for sway.  Balance Recovery will 
always go first.  Use “randperm(3)” to determine the order of the other tasks.  1= gait initiation, 2= sway, 
3= gait. For sway, use “randperm(6)” and each even number it gives= eyes open trial, and each odd 
number= eyes closed trial.  Write the orders on the data collection sheet and on the the whiteboard.  
 
Loading the Pull Device 
Take the subject’s weight on the force plate. Add 10 lbs to account for the weight of all of the sensors and 
rigid harness.  
Go to the “Pull Weight Combinations” sheet and look up the weight to add amount. Remember that the 
actual amount of weight you will add is 7 lbs less than what it says in the “weight to add” column. If you 
add the weight together from the weight combinations that it gives, that is the right amount to add. Or, 
you can just subtract 7 lbs from the amount it tells you to add. 
To determine the drop distance, measure the distance from the middle of the waist harness loop that the 
rope connects in to the floor. Take 8.7% of this number and then add 0.5cm.  So the calculation is waist 
height*.087 + 0.5 cm.   
To set the drop distance, note that a “zero” distance is 11cm on the meter stick that is in the device.  So 
you will want to move the brushes to whatever drop distance you calculated + 11cm.   
Optotrak Setup 
Place Optotrak sensors in location- 12 feet from midline of force plates on East and West sides 
Connect 3020 and Certus sensors to the SCU using the correct cables (they are labeled). Ensure that the 
cable from the SCU to the computer is connected, and that the power is connected. 
Turn on both sensors and the SCU unit. 
Start up the optotrak computer, logon, and open First Principles 
Choose FileNew Experiment 
Perform a new registration and alignment with coordinate system origin at the SE corner of force plate #3.  
*Note- if the software does not detect both sensors it will not ask you to perform a registration- make sure 
that it finds both sensors. If it doesn’t, try “Query System,” and then start the setup over again. 
Note that sensor 3-03-63 is the 3020 system. 
Connect all markers and strobers and make sure the software recognizes the correct number of markers.  
You can go through and name them here as well if you want to.  
Choose to enable the trigger 
Setup your data collection parameters 
Make sure that all markers are visible. 
 
Force Plate Setup 
Turn on and leave alone for 10-15 minutes 
Balance amplifiers 
Take zero trial prior to data collection 
 
EMG Setup 
Scrub area with pumice stone and rub with alcohol wipe 
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Place sensors and arrange wires 
Connect output cables 
Ensure that the gain is turned to 1k on all 8 channels 
Check signal using labview 
 
Labview Startup 
Open My DocumentsResearchMollyPD Project 2010Labview Vis and open the 
“PD_data_collection_allinone.” 
After balancing force plates, take a force plate zero trial. 
-Set collection time to 1 sec 
-Select “no” for “Use Trigger?” 
-Select “no” for “Do you want to track the COP before data collection?” 
-Save the zero trial as My DocumentsResearchMollyPD Project 2010Data 
Then choose the appropriate experiment folder and label file as “fp_zero” 
 
For the balance recovery experiment,  
Have the subject stand on force plates one and two in the same position as they will stand for the balance 
recovery task.  Mark the feet with tape. Take a trial and label it “still” This will serve as the static trial, 
too- so make sure that all markers are visible and use the trigger to collect optotrak data.  
Run “zero trial calculation simplify” VI to calculate the still position COP. Save the file as “still_cop.” 
Now open PD_data_collection_allinone and select “yes” to monitor the COP and “yes” to use the trigger.  
Set the collection time to 5 seconds. 
Make sure that the drop mechanism is ready to go (hit “open cleats” and front “drop” and front “cleat” to 
arm it.   
Begin the VI by pushing the start arrow on the upper left hand side of the window. 
When the green light comes on (indicating they have met the COP requirements), click on the “GO” 
button. Now the program is waiting for your trigger. 
Press the red trigger button to trigger optotrak, labview, and to drop the weights. Weights are dropped 
500ms after data collection begins. 
Save the trial as br1.  Note on the data collection sheet which optotrak file goes with which data file. 
Check that all of the data looks good 
 
For all other tasks, 
-Select “no” for “Do you want to track the COP before data collection?” 
Take another fp_zero trial (1 sec), and save it in the correct task folder.  
Gait Initiation trials are 5 seconds (unless they need to be adjusted for a very slow subject), Sway trials 
are 30 seconds, and we don’t need to collect data through labview for gait trials. 
Gait initiation also needs a static trial- only marker data is needed, but all markers must be in view. Static 
trials are 5 seconds long.  
 
Post Data Collection Tasks 
File Backup: 
Take “PD Project Data Transfer” external hard drive from out of Molly’s desk and transfer the optotrak 
files to the hard drive.  
Connect the video camera to the Labview computer and turn it on.   
Connect the external hard drive to the Labview computer. 
Copy the video and optotrak data to the appropriate folder in the Labview computer. 
Copy all files from the labview computer folder to the “Master Backup Hard Drive” (the 1 TB one that 
sits on the desk by the labview computer) and also to the transfer hard drive. 
 
 
D-4 
Double check that you have complete sets of data on both the labview computer, the transfer hard drive, 
and the master backup hard drive.  
Someone should take the transfer hard drive home with them each night.  
 
DT Timesheet 
Update the spreadsheet “DT Timesheet” with the date and hours that he worked.  
 
Payment and Thank You’s: 
At the end of a testing week, collect all of the payment forms out of the folders of each participant.  
Complete the back side of the forms, and take to Carl to sign.   
Make copies of the signed forms for our records and turn in the originals to Leslie in the ME office. 
Write and send a thank-you card from our lab to the participant.  
 
PD Patient Appt. with Dr. Lyons Record 
Dr. Lyons needs to know about each patient that we test and when we test them.  Update the spreadsheet 
called “Testing Dates” to include each PD participant.  Really this should be updated as soon as the 
patient is scheduled in case they go in to see Dr. Pahwa between scheduling and testing.  
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Experimental Protocol 
0-45 minutes: Subject Paperwork, Health Assessments, Measurements 
Location: subject setup area 
 
-Consent Form 
-Take weight on force plates 
-Questionnaires 
-Offer a bathroom break! 
-Change into shorts, socks, shoes, T-shirt 
-Health Assessment, take weight and height 
-Measurements 
Laying down: Leg Length, ASIS distance, ankle width 
Sitting up: calf circumference 
Standing: knee width, ankle height, food width, foot length, thigh circumference 
*While taking measurements, mark placement for Knee Marker, ASIS, great troch, and hamstring EMG. 
 
Measurement Descriptions: 
Weight: When the subject first arrives, weigh with shoes and clothes on on force plates.  Then, after the 
subject has changed into testing clothing, weight without shoes on on force plates again.  
ASIS Breadth: Measure the horizontal distance between the two ASIS 
Thigh length: Measure the vertical distance between the top of the great troch and the top of the lateral 
tibia (can use tibial plateau). 
Thigh Circumference: Measure mid-thigh 
Calf Length: Measure the vertical distance between the top of the lateral tibia and the lateral malleolus 
(ankle).  
Calf Circumference: Measure the circumference of the calf at the largest spot. 
Knee Diameter: Measure the maximum breadth of the knee across the femoral epicondyles. 
Foot Length: Measure the distance from the back of the heel to the tip of the longest toe. 
Ankle height: Measure the vertical distance from the floor to the lateral malleolus. 
Ankle width: Measure the maximum distance between the medial and lateral malleoli. 
Foot width: Measure the width across the distal ends of metatarsals 1 and 5.  
 
45-90 minutes: Sensor placement and Equipment Setup 
Location: Platform Area 
 
Put safety harness on. 
 
Place EMGs: bilateral TA, gastroc, hamstring, quad 
Connect EMG as follows: 
EMG lead Muscle  EMG out-> DAQ Board Channel in 
#1   R TA   1 – 22 
#2   R gastroc  2 – 23  
#3   R solius/ham  3 – 24  
#4  R quad   4 – 25    
#5  L TA   5 – 26  
#6   L gastroc  6 – 27  
#7   L solius/ham  7 – 28  
#8  L quad   8 – 29 
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Test EMGs, take sitting break 
 
Optotrak Markers 
15 markers will be placed on the lower body as follows (see Vaughan’s Gait Model and Helen Hayes 
Marker Set for more information about specific placement methods): 
Complete Setup: Bilateral – ASIS, sacrum, thigh, knee, shin wand, ankle, heel, toe 
Modified Setup(for balance recovery only): Bilateral- greater trochanter, thigh, knee, shin wand, ankle, 
heel, toe 
 
Marker Placement Tips: 
ASIS/Sacrum: tape around the waist, and then attach markers to the tape. Use a foam piece to orient the 
sacrum towards one of the cameras. 
Thigh: Find greater trochanter, have subject rotate their foot to make sure you have it, then place marker 
on the line between the greater troch and knee (along the long axis of the thigh). Marker should be on 
lower thigh and in line with the flexion/extension axis of the knee.  
Knee: Identify tibial plateau, then move back and up to find the femoral epicondyle- along the 
flexion/extension axis of the knee.  
Shin Wand : Place on lower shank, on long axis, and in line with flexion/extension axis of the ankle. 
Heel: Place on shoe, at same height of toe marker, use a foam piece to orient the marker towards the 
cameras.  
Ankle: Place marker in line of flexion/extension axis of ankle. 
Toe: 2
nd
 metatarsal head on joint closest to body  (2
nd
 biggest) Use a foam  piece to orient the marker 
towards the cameras. 
 
Walk subject into data collection area and test to make sure all markers are visible. 
Subject calibration trial (stand still)  
Take a sitting break 
 
90-180 minutes: Experimental Testing/Data Collection 
Location: Platform Area 
Balance Recovery (trial type: general w/analog/ trial name: pull1) 
The balance recovery testing consists of 3 backwards pull trials.  Force plate, EMG, and motion data will 
be collected during all trials.  The weight-drop device will be used to pull the participant. 
Should have modified marker setup (no sacrum or ASIS, but including great troch markers) 
 
Attach safety harness 
TAKE STATIC TRIAL IN MODIFIED MARKER SETUP 
Mark foot position with tape 
Put on the rigid harness 
Measure waist height, adjust pull device to 8.7% of waist height 
Take a still trial 
Mark the feet so they stay in the same position as for the “still trial.” 
Attach pull device cable 
Read script, explaining task (no practice trials) 
Start the video camera 
Research assistant should spot the participant throughout all trials 
Once subject is ready, release the weight-dropping mechanism 
Replace weights and  tell the subject to relax after they have regained their balance for three seconds 
Check trial for marker visibility  
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Perform a total of 3 trials with 30 seconds rest in between trials 
Disconnect safety harness, cable to pull device, and remove rigid harness 
Take a sitting break 
 
 
Sway (trial type: PD_sway/ trial name: sway1) 
Sway testing consists of three trials in each of two different conditions, eyes open (EO) and eyes closed 
(EC). Force plate, EMG, and motion data will be collected. Each test will last 30 seconds with 30 seconds 
of rest in between trials. 
Should have complete marker setup 
 
Have participant stand comfortably with one foot on each force plate. Feet should be shoulder wide and at 
a self-selected angle.  Arms rest to the side and the subject is looking at a marker placed 5 feet in front of 
the at approximately eye height.  
Attach safety harness 
Check EMG and visibility of markers  
Read script to the participant 
Before each test, remind the participant of the condition being tested (EO or EC). 
Take a sitting break 
 
Gait Initiation (trial type: general w/analog/ trial name: gait_ini1) 
Participants will perform 5 gait initiation trials, all starting from standing on a forceplate. EMG, force and 
movement data will be collected. 
Should have complete marker setup 
 
Have participant stand in collection area with one foot on each force plate. They will be oriented so that 
they are looking at the South wall. 
Take a static trial 
Mark foot position 
Attach safety harness 
Read the script to the participant. 
Subject will start with one foot on each force plate, then step forward when the light comes on. 
Participant should start each trial with their feet in a comfortable stance and their arms relaxed at their 
sides. 
A research assistant should be spotting the participant throughout. 
Take a sitting break 
 
Gait (trial type: PD_gait/ trial name: gait) 
Participant will walk on the treadmill for 3 minutes at a self-selected speed.  EMG and movement data 
will be collected. 
Should have complete marker setup, foot switches, EMG on gastroc, hamstring, TA, quad 
 
Move treadmill into the collection volume under the safety support. 
Instruct participant to step onto the treadmill. 
Attach the cable to the safety harness. 
Attach kill switch to subject’s clothing. 
Power up the treadmill. 
Read the script to the participant, explaining the tasks. 
Slowly increase the speed of the treadmill until the desired speed is reached. Record the final speed on the 
data collection sheet. 
 
 
D-8 
Once the participant has reached a comfortable gait begin data collection. 
At the end of data collection, inform participant they are finished and then stop the treadmill (manually 
decrease the speed to zero). 
Remove safety cable and assist the participant in stepping off the treadmill. 
 
Take another subject calibration trial (should have two subject calibration trials- one for use with br, one 
for all others)  
 
Take another force plate zero trial 
 
 
Optotrak Data Key 
Marker Location Columns 
1 Right Thigh 2:4 
2 Right Knee 5:7 
3 Right Shank 8:10 
4 Right Ankle 11:13 
5 Right Heel 14:16 
6 Right Toe 17:19 
7 Left Thigh 20:22 
8 Left Knee 23:25 
9 Left Shank 26:28 
10 Left Ankle 29:31 
11 Left Heel 32:34 
12 Left Toe 35:37 
13 Right ASIS/Great Troch 38:40 
14 Sacrum 41:43 
15 Left ASIS/Great Troch 44:46 
 
Pre Data Collection Tasks 
Recruitment: 
Once a participant has passed the health screen and is scheduled, send them a confirmation letter and 
directions to the lab.   
If it is a PD participant, also email them to ask them to see Dr. Lyons within 3 months of the testing date.  
Attach the letter called “UPDRS Appt.”  
Email David to confirm testing dates/times.  
Misc: 
Email David Moore, parking guy, about reserving a parking meter. His email is moore-ku@ku.edu and 
phone number is 785-864-7293 (office) or 785-840-5693 (cell).  
Make sure David Thomas has a parking pass for the week of testing. If there are 3 or more tests in a week 
it makes sense to get him a weekly parking permit.  A red weekly visitor permit is $8.00/week.  Contact 
Mary Olson at KU Parking. I just sent an email to kupark@ku.edu and that is who responded to me.  You 
can either pay for the permit and get reimbursed or ask them to invoice the ME department (specify that 
this is for Luchies’s PD Pilot project so the office knows what it is).  If there are 2 or fewer tests in a 
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week, it makes sense for him to just park in the parking garage and pay $1/hour.  In this case, we add the 
parking fee to his timesheet (there is a column for parking).  Just note the number of hours he parked for.  
Email Kelly Lyons (klyons@kumc.edu) to let her know if we are testing a PD patient so she can make 
sure and see them in clinic in case they happen to have an appointment before they come in for testing.  
Make sure the laundry is all clean (sheets, shorts, socks, etc).   
 
 
Post Data Collection Tasks 
File Backup: 
Take “PD Project Data Transfer” external hard drive from out of Molly’s desk and transfer the optotrak 
files to the hard drive.  
Connect the video camera to the Labview computer and turn it on.   
Connect the external hard drive to the Labview computer. 
Copy the video and optotrak data to the appropriate folder in the Labview computer. 
Copy all files from the labview computer folder to the “Master Backup Hard Drive” (the 1 TB one that 
sits on the desk by the labview computer) as well as on the PD Project Data Transfer hard drive. 
Double check that you have complete sets of data on both the labview computer, the master backup hard 
drive, and the transfer drive.  
Take the transfer drive home with you.  
DT Timesheet 
Update the spreadsheet “DT Timesheet” with the date and hours that he worked and any parking that we 
owe him for.  
Payment and Thank You’s: 
At the end of a testing week, collect all of the payment forms out of the folders of each participant.  
Complete the back side of the forms, and take to Carl to sign.   
Make copies of the signed forms for our records and turn in the originals to Leslie in the ME office. 
Write and send a thank-you card from our lab to the participant.  
PD Patient Appt. with Dr. Lyons Record 
Dr. Lyons needs to know about each patient that we test and when we test them.  Update the spreadsheet 
called “Testing Dates” to include each PD participant.  Really this should be updated as soon as the 
patient is scheduled in case they go in to see Dr. Pahwa between scheduling and testing.  
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PD Pilot Protocol: Checklist 
 
Start Equipment Setup: 
_____Check camera positions 
_____Turn on force plates, cameras, SCU 
_____Verify force plates (channels 0-11,16-21), EMG (channels 22-29), pull device load cell 
(channels 12-13), gait initiation light (channel 14), and trigger (PFIO) are connected to DAQ 
board 
_____Connect video camera 
_____Connect pull device – normal (channel 12), shear (channel 13) 
_____Balance force plates 
 
Start Subject Setup: 
_____Consent  
_____Physical Screening 
_____Clarify history (falls in previous 3 months, severity and duration, medication  
status) 
_____Mini-mental exam 
_____5 Self-Report Tests  
 
Complete Equipment Setup: 
_____Complete Optotrak startup (registration, calibration) 
_____Collect a FP zero trial for tracking drift (trial name: FPzero1)  
_____Calculate appropriate weight for pull and load pull device (see paper) 
_____Test Pull Device 
_____Place “GO” switch box and target  
 
Complete Subject Setup: 
_____Measurements and EMG Placement 
_____Optotrak markers 
_____Put harness on 
_____Put EMG belt on 
 
Data Collection: 
_____Connect markers and make sure they are all seen in Optotrak 
_____Collect a subject calibration trial (static trial) 
_____Check that movie camera is working  
_____Check to make sure all markers are visible  
_____Check EMG signal 
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Sway (trial name: sway1EO) 
3 EO/3 EC Each test will last 30 seconds with 30 seconds of rest in between trials. 
Should have complete marker setup, EMG on gastroc, SOLEUS, TA, quads 
 
_____Disconnect Solius EMG channel and connect to hamstring electrode 
 
Balance Recovery (trial name: pull1) 
3 Backward Pull Trials 
Should have modified marker setup (no sacrum or ASIS, but including great troch markers), 
EMG on gastroc, hamstring, TA, quad 
 
_____Change markers: move calf and thigh markers out of alignment with knee, ankle, and hip 
markers. Add a great troch marker if not already in place. Remove ASIS markers. 
_____Take a static trial for use with BR (w/troch markers) 
_____ Put on the rigid belt 
_____Calculate weight drop height (8.7% of waist height) and adjust- measured from brushes 
_____Perform a total of 3 trials with 30 seconds rest in between trials 
_____Check each trial in Optotrak 
_____Remove belt 
 
Gait Initiation (trial name: gait_ini1) 
5 trials, all starting from standing with one foot on each force plate 
Should have complete marker setup, EMG on gastroc, hamstring, TA, quad 
 
_____Check each trial in Optotrak 
 
Gait (trial name: gait) 
Participant will walk on the treadmill for 3 minutes at a self-selected speed.   
Should have complete marker setup, foot switches, EMG on gastroc, hamstring, TA, quad 
 
_____Take another force plate zero trial 
_____Make sure that you have two static trials 
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Data Collection Sheet 
 
Date: __________________  Time: ____________  Subject #: ___________ 
Engineer: ______________  Testing Order: _______________________________ 
Engineer: ______________ 
PA: ___________________ 
 
PD Duration: ____________ 
 
PD Medications (list other medications on health screen): 
Name: _____________________Dosage: __________  Frequency: __________ Last Dose: __________ 
Name: _____________________Dosage: __________  Frequency: __________ Last Dose: __________ 
Name: _____________________Dosage: __________  Frequency: __________ Last Dose: __________ 
Name: _____________________Dosage: __________  Frequency: __________ Last Dose: __________ 
Name: _____________________Dosage: __________  Frequency: __________ Last Dose: __________ 
Name: _____________________Dosage: __________  Frequency: __________ Last Dose: __________ 
 
Fall History: 
Falls in previous 3 months: 
Date: _____________ Description: __________________________________ 
 
Date: _____________ Description: __________________________________ 
 
Date: _____________ Description: __________________________________ 
 
Date: _____________ Description: __________________________________ 
 
Mini-Mental Score: ___________ 
 
Measurements: 
Height:       ________________________ 
Weight:       ________________________ 
Leg Length (ASIS to medial ankle via knee):    L: ________  R: _________ 
Inter ASIS distance:     ________________________ 
Knee Width (between femoral condyles):   L: ________  R: _________ 
Ankle Width:      L: ________  R: _________ 
Foot Width:      L: ________ R: _________ 
Foot Length:      L: ________ R: _________ 
Thigh Length (troch. to lat’l tibial plateau): L: ________ R: _________ 
Calf Length (lat’l tibial plateau to lat’l mall.): L: ________ R: _________ 
Ankle Height:     L: ________ R: _________ 
Calf Circumference (largest pt.):   L: ________ R: _________ 
Thigh Circumference (mid-thigh):    L: ________ R: _________ 
Waist Height:      ________________________ 
Weight loaded for pull device: 
 
Drop distance for pull device:    
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Testing Notes: 
 
EMG Check: ____________________________________________________________ 
 
Sway (30 seconds @ 1000Hz EMG/FP, 100Hz Opto) 
Need 3 EO and 3EC perfect trials 
*Most important data- force plates and EMG 
 
Trial 
Video 
File Name 
Labview 
File Name 
Optotrak 
File Name 
Trial 
Notes 
FPzero     
Sway1     
Sway2     
Sway3     
Sway4     
Sway5     
Sway6     
     
     
 
 
Balance Recovery (5 seconds @1000 Hz EMG/FP, 100Hz Opto) 
Need 3 perfect trials 
*Most important data- force plates, EMG (TA), markers (up to knee, both sides), load cell 
channels, video 
Trial 
Video 
File Name 
Labview 
File Name 
Optotrak 
File Name 
Trial 
Notes 
FPzero     
Static 
Trial 
    
Pull1     
Pull2     
Pull3     
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Gait Initiation (5 seconds @1000 Hz EMG/FP, 100Hz Opto) 
Most important data: force plates, gait initiation light, EMG (all), markers (all). Watch for a clean 
force plate strike on fp3 for the first step.  If it is not a clean strike, the trial is not good.  
Need 5 perfect trials 
Trial 
Video 
File Name 
Labview 
File Name 
Optotrak 
File Name 
Trial 
Notes 
FPzero     
Static 
Trial 
    
Gait_ini1     
Gait_ini2     
Gait_ini3     
Gait_ini4     
Gait_ini5     
     
     
     
 
 
 
Gait (100 Hz Opto only) 
Most important data: Markers (all)- this is all we have for gait. 
Trial 
Video 
File Name 
Labview 
File Name 
Optotrak 
File Name 
Trial 
Notes 
Static 
Trial 
 n/a   
Gait  n/a   
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Parkinson’s Study Scripts 
 
Postural Sway 
“For this set of tests you will stand here with your hands to your sides and have either your eyes 
focused on the picture in front of you or have them closed.  We will do several trials with rest in 
between. I will tell you when to begin each trial and I will tell you when to relax.” 
 
EO: 
Instructions to subject:   
“For this test, you will stand as still as possible.  Focus your gaze at the target in front of you”   
 
EC: 
Instructions to subject:   
“For this test, you will stand as still as possible with your eyes closed.  Keep your eyes closed until the 
end of the trial.” 
 
Gait Initiation :6 trials start with feet on force plates and check for clean strike on back force plate 
(capture push off and first step) 
 
Instructions to subject:  
“For this set of tests you will start standing still and then begin walking when you see the green light. 
Keep walking until I tell you to stop. You will take approximately 3-4 steps. We will do several trials 
with rest in between. 
 
Repeat for each trial: 
“For this test, you will stand here as still as possible and when you see the green light you will start 
walking forward, looking ahead while you walk.” 
 
Balance Recovery: 3-5 trials 
Instructions to subject: 
“This study will let us look at your response to a balance disturbance.  You will be asked to stand 
here on these force plates and a cable will be attached to your waist. The cable will pull you 
backwards and you need to regain your balance. We will have you repeat this several times.  We 
will explain each step and give you a rest between trials.” 
“First we will have you put on this waist belt, which will be attached to the cable that will pull you 
for each trial.  For your safety, you will wear a safety harness.  The harness will catch you if you are 
unable to regain your balance.” 
“Now, we will have you place your right foot on this plate and your left one on this plate.  Stand 
comfortably with your feet approximately shoulder-width apart. Please stand quietly with your hands at 
your sides. Please remain as still as possible before and after you regain your balance, until I tell you 
to relax. Do you have any questions? 
“Okay, now we will start the test.  Please remember to stand up straight and remain still before the pull 
and after you step.” 
 
Gait: 1 trial 
Instructions to subject: 
“For this test you will walk on this treadmill for approximately 3 minutes at a pace that is comfortable 
for you. First we will determine a pace and then the test will begin. Again, you will wear a safety 
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harness that will catch you in the event that you lose your balance.  Also, if at any time you feel 
uncomfortable, you can push this button and the treadmill will stop abruptly.” 
“First, we will start the treadmill slowly and choose a speed that feels like a comfortable, normal 
walking pace to you.  Do you have any questions?” 
(Choose pace) 
“Now, we will start the test. Just continue to walk normally. The test will last approximately 3 
minutes.” 
 
 
 
 
